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 Obesity is the leading cause of chronic disease and has contributed to significant 
health problems and complications. In order to solve this increasingly serious social 
problem, it is particularly important to deepen the understanding of the biological causes 
of obesity. Obesity is the result of an increased mass of adipose tissue after excessive 
caloric intake, and adipogenesis is the main strategy through which the body increases the 
number of adipocytes. However, due to the lack of research, the current understanding of 
adipogenesis is not enough to yield results in the clinic. 
The regulation of adipogenesis is complex, and the role of the Notch signaling 
pathway in adipogenesis has long been controversial, as the role of individual Notch 
receptors appears to vary with experimental conditions. In this dissertation, we 
demonstrate that in human adipose-derived stem/stromal cells (hADSCs), Notch1 and 
Notch3 have distinct expression profiles and roles during adipogenesis. Expression of 
these Notch receptors changed during adipogenesis with Notch3 expressed prior to the 
formation of lipid vesicles and Notch1 only appearing after vesicle formation. In 
addition, the siRNA-mediated Notch3 knockdown demonstrated an increased expression 
of PPARγ, an adipogenic marker, which was paralleled by a marked decrease in 
expression of β-catenin, the key functional component of the canonical Wnt/β-catenin 





the distinct roles of Notch1 and Notch3 during adipogenesis offering a novel therapeutic 
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1.1 The Nature of Lipid Metabolism 
1.1.1 Obesity 
Obesity is a pathological result of the body storing surplus energy and 
contributing to the mass of white adipose tissue (WAT). By increasing the body's 
mechanical burden and causing a variety of chronic diseases, obesity significantly 
reduces the quality of life and even increases the risk of death. Although the problem of 
obesity can be solved through lifestyle changes, the increasing number of obese patients 
proves that not everyone follows those guidelines. As long-term effective treatments have 
not yet been identified, a better understanding of lipid metabolism has become a leading 
course for research in recent years. 
White adipocytes in WAT are mainly responsible for storing surplus triglycerides 
(TGs) in lipid droplets. Therefore, under the condition of overnutrition, the mass of WAT 
increases via two main paths: hyperplasia and hypertrophy. Hyperplasia is when the body 
responds to surplus energy by increasing the number of white adipocytes. However, the 
efficiency of hyperplasia becomes limited over time. As people age, additional nutritional 
intake may cause the occurrence of hypertrophy, which is the  increase in cell size that 





Blüher, 2014). In general, hypertrophy is not an ideal strategy for energy storage since 
the rapidly increased cell size affects the cellular oxygen uptake but does not actively 
induce angiogenesis in the surrounding tissue. The unsatisfied oxygen consumption 
directly forces adipocytes to start expressing fibrosis-related proteins resulting in fibrosis 
of the surrounding tissue and corresponding local inflammation (Khan et al., 2009). The 
hypoxia also triggers the endoplasmic reticulum stress and increases autophagy of 
adipocytes (Klöting & Blüher, 2014). Finally, the increased cell volume has a positive 
correlation with insulin resistance, further exacerbating the energy metabolism disorder 
(Halberg et al., 2009).Therefore, a deeper understanding of the mechanism of hyperplasia 




Hyperplasia relies on continued adipogenesis from adipocyte precursors. 
Adipogenesis covers the entire process from stem cells to mature adipocytes and is 
divided into two stages: commitment and terminal differentiation. Following adipogenic 
induction, these fibroblast-like cells undergo additional replication until commitment is 
initiated by cell contact. These multipotent precursors then become preadipocytes that are 
restricted to the adipocyte lineage. Preadipocytes exit the cell cycle and subsequently 
initiate terminal differentiation that requires excessive nutrition and the accumulation of 
TGs in multiple micro lipid vesicles. A sufficient number of lipid vesicles then fuse into a 






At the molecular level, following commitment, the BMP2 and BMP4 signaling 
cascades are activated to stimulate further differentiation (Figure 1-1) (Modica & 
Wolfrum, 2017; E. A. Wang, Israel, Kelly, & Luxenberg, 1993). In addition, C/EPBP is 
expressed to activate the transcription of C/EBP and PPAR. C/EBP and PPAR are 
adipogenic master regulators as well as transcriptional activators of each other. This 
positive feedback loop further stimulates the transcription efficiency of these two 
molecules and the overall process of adipogenesis (MacDougald & Mandrup, 2002). 
PPAR is a decisive nuclear receptor that controls the progress of adipogenesis, and its 
expression is widely used as a marker of early adipogenesis. It has long been established 
that PPAR is a master regulator of adipogenesis and that the absence of PPAR alone 
prevents adipocyte differentiation (Rosen et al., 1999), while the activation of 
PPAR only is sufficient to initiate the adipogenic program in fibroblasts (Tontonoz, Hu, 
& Spiegelman, 1994). As a member of the nuclear receptor superfamily, PPAR 
dimerizes with retinoid X receptor (RXR) and subsequently activates the transcription of 
target genes, fabp4, lpl, gk, and aqp7 to regulate aspects of adipogenesis including 
nutrient intake, insulin sensitivity, fat accumulation, and transport (de sá, Richard, Hang, 
& Stephens, 2017; Koppen & Kalkhoven, 2010). Finally, in the process of maturation, 
cells gradually initiate and increase the expression of adipokines such as adiponectin and 
leptin to regulate physiological progress. Therefore, PPAR, FABP4, LPL, adiponectin, 






Figure 1-1: hADSC adipogenesis in vitro. hADSCs undergo commitment and 
terminal differentiation to become mature adipocytes after the induction of adipogenic 
media. The key molecular changes are shown above, and cell morphology changes are 
shown below. 
1.2 Cell Types for in vitro Study of Adipogenesis  
1.2.1 In vitro Adipogenic Induction 
In vivo and in vitro experiments are the most utilized means of studying fat 
differentiation. Among these, in vivo experiments often focus on validating the 
integrative biological effects of a particular molecule or treatment on lipid metabolism in 
the whole living organism. Due to limitations such as high cost and long life cycle of 
animal models, it is difficult to repeat a large number of in vivo experiments required in a 
short period of time to deepen the understanding of adipogenic differentiation. Moreover, 
because of the complexity of regulation of adipogenic differentiation and metabolism in 
living organisms, mining specific regulatory mechanisms with in vivo studies becomes 
challenging. Correspondingly, in vitro experiments that rely on adipose precursors or 





the mechanisms at a molecular level. Due to the advantages of easy manipulation, 
induction of differentiation, and expansion of cell samples, the number of reports on in 
vitro adipogenic differentiation and metabolism have increased over the years. 
Although it is challenging to fully mimic the physiological conditions of in vivo 
adipogenesis, years of research have reached some consensus on in vitro conditions to 
induce adipogenesis of cellular precursors. The most commonly used chemical and small 
molecule cocktails used to induce adipogenesis consist of fetal bovine serum (FBS), 
isobutylmethylxanthine (IBMX), dexamethasone, and insulin. FBS provides a basic 
source of nutrients for cell survival; IBMX elevates the level of cyclic adenosine 
monophosphate (cAMP); dexamethasone is the ligand for the glucocorticoid receptor 
(GR), a nuclear hormone receptor that promotes the expression of PPAR and C/EBP 
families; and insulin which promotes the efficiency of nutrient intake to accelerate lipid 
accumulation (Novakofski, 2004). Under such in vitro induction conditions, adipose 
precursor cells are capable of undergoing major morphological and molecular processes 
of in vivo adipogenesis. 
 
1.2.2 Murine-Derived Cell Lines 
To study in vitro adipogenesis, several murine cell lines have been established. 
For instance, two cell lines were developed from mice to facilitate the study of 
adipogenesis: C3H10T1/2 and 3T3. The C3H10T1/2 cell line was established from C3H 
mouse embryonic stem cells to study the commitment of adipogenesis (Ruiz-Ojeda, 
Rupérez, Gomez-Llorente, Gil, & Aguilera, 2016). Another two murine Swiss 3T3 cells 





which are often used to study the differentiation process after commitment (Green & 
Kehinde, 1974, 1976). Murine-derived cell lines have been utilized for decades, but as a 
number of applications proven in mouse models then failed in human trials, establishing 
human cell lines became essential for the study of human adipogenesis (Uhl & Warner, 
2015). 
 
1.2.3 Human Adipose-Derived Stromal/Stem Cells 
The discovery and successful isolation of adult human stem cells provides 
favorable conditions for studying human cell activity in vitro. Human adipose-derived 
stem cells (hADSCs) are widely used adult stem cells due to their multipotency, 
immunosuppressive effect, and ease of in vitro culture and manipulation (Ruiz-Ojeda et 
al., 2016). Because hADSCs are directly isolated from donor adipose tissues, hADSCs 
also have the advantages of easy isolation, abundance, and a small burden on donors. It is 
noteworthy that the homogeneity of isolated hADSCs can vary due to the complexity of 
the adipose tissue. Therefore, hADSCs are more often called human adipose-derived 
stromal/stem cells to expand the scope of adaptation.  
Since the natural role of hADSCs is to maintain the level of adipocytes in WAT 
via adipogenesis, they are considered to be the most representative cell line for studying 
the complete process of human fat differentiation (Cawthorn, Scheller, & MacDougald, 
2012). However, due to the individual differences of donors and the physiological 
differences of WAT from different parts of body, some outcomes resulting from the study 
of hADSCs do differ. For instance, hADSCs from aged donors appear to have a weaker 





subcutaneous WAT-isolated ADSCs are more sensitive to adipogenic induction than 
those cells isolated from visceral WAT (Macotela et al., 2012). These differences 
contribute to questions about the reliability of using hADSCs in certain types of 
experiments. However, when donor information is provided, different donor samples can 
be used to study the characteristics of adipogenesis in the presence of different genetic 
traits and metabolic-related diseases by comparing the characteristics of hADSCs from 
different donors. Therefore, as long as researchers accurately represent and characterize 
the source and properties of hADSCs used in their studies, hADSCs provide a valuable 
and commonly used human cell type for studying the process of adipogenesis. 
 
1.3 Notch Signaling Pathway 
1.3.1 Notch Signaling pathway 
First identified and defined by Tomas Hunt Morgan in 1917 (Morgan, 1917), 
Notch remains one of the most critical pathways in the processes of  cell proliferation, 
differentiation, metabolism, and apoptosis. The role of Notch in regulating adipogenesis 
was first published in 1997 (Garcés et al., 1997). However, because of the large number 
of contradictory outcomes, more than two decades of continuous research have still not 
provided a clear role for Notch in adipogenesis. Therefore, a deeper understanding is 
crucial to the advancement of research in this field. 
Notch is a highly conserved contact-dependent signaling pathway composed of 
ligands, receptors, and downstream protein and genomic targets. As Figure 1-2 shows, 
the Notch receptor stays inactivated on the surface of the membrane of the signal-





sending cell). The Notch receptor then releases its activated form, the Notch intracellular 
domain (NICD), into the cytoplasm following the completion of two cleavages mediated 
by a disintegrin and metalloproteinase domain 17 (ADAM17) metalloproteinase and the 
γ-secretase complex. Without the activation of Notch, the transcription of Notch target 
genes remains repressed by the inactive CBF1/Su(h)/LAG-1 (CSL) complex. When the 
NICD is translocated into the nucleus, the CSL complex becomes activated and Notch 
targets such as Hairy/Enhancer of split (Hes) and basic helix-loop-helix (bHLH)-type 
transcriptional repressors (Hey) are transcribed to regulate cell fate. 
 
Figure 1-2: The activation of the Notch signaling pathway. DSL= Delta-Serrate-Lag2 
region of Notch ligands, NICD= Notch intracellular domain, CSL= 
CBF1/Su(h)/LAG-1 (CSL) complex, and MAML= mastermind-like transcriptional 






1.3.2 Components of the Notch Pathway 
Notch receptors 
 In mammals, there are four Notch receptors (Notch1-4), which all share the basic 
structure of a single transmembrane receptor including a Notch extracellular domain 
(NED), a transmembrane (TM) region, and a Notch intracellular domain (NICD) (Figure 
1-3 A). The NED is the ligand binding domain and contains a  number of epidermal 
growth factor (EGF)-like repeats, ranging from 29 to 36 in different receptors, that 
ultimately determine the affinity of the NED for specific ligands. The Notch Negitive 
Regulatory Domain (NRR) is composed of three juxtamembrane Lin Notch Repeats 
(LNRs) along with a heterodimerization domain (HD) and the cleavage site for ADAM 
metalloprotease. The NICD is the main functional unit of the Notch receptor and is 
composed of an Rbp-associated molecule domain (RAM), seven ankyrin (ANK) repeats, 
and a degradation region consisting of Proline, Glutamic acid, Serine, and Threonine-rich 
residues (PEST). In addition, Notch1 and Notch2 have a transactivation domain (TAD) 
between the ANK repeats and PEST domain, but the function of a similar region in the 
Notch3 and Notch4 receptors remains unknown (Siebel & Lendahl, 2017). 
Notch ligands  
There are two types of Notch ligands: canonical and non-canonical. Canonical 
ligands include Delta-like (Dll) 1, 3, and 4, and Jagged (Jag) 1 and 2 which belong to the 
Delta-Serrate-Lag2 (DSL) superfamily (Figure 1-3 B). These single trans-membrane 
ligands consisit of a DSL region and EGF-like repeats in the extracullar domain for 
ligand-receptor connection. Jag1 and 2 also have von Willebrand factor type C (vWFC) 





Notch ligands include delta-like non-canonical ligand (Dlk) 1 and 2, which are 
structurally similar. Unlike the canonical ligands, the non-canonical ligands have an 
additional cleavage site for ADAM17 and the extracellular domain of mature ligands is 
not membrane bound. Therefore, these soluble ligands are capable of traveling and 
binding to receptors on non-adjacent cells (D’Souza, Meloty-Kapella, & Weinmaster, 
2010). 
 
Figure 1-3: Structural illustration of Notch receptors and canonical ligands. The left 
side of the cell membrane indicates the extracellular region, and the right side 
illustrates the intracellular region. The number of EGF repeats in the extracellular area 
is calibrated numerically. The figure was generated based on the information from the 







CSL, also referred to as recombination signal binding protein for immunoglobulin 
kappa J region (RBP-J) in Homo sapiens, is composed of the LAG1-DNA binding 
region, the beta-trefoil domain (BTD), and the IPT-RBP-Jk domain (E. C. Lai, 2002). 
The early model stated that, without NICD, the CSL complex constitutively binds to 
target DNA sequences to block transcription by recruitment of co-repressors. The RAM 
and ANK region of NICD then recognize and bind to BTD and IPT-RBP-J respectively 
to replace co-repressors on CSL and recruit the transcriptional co-activator Mastermind 
(MAM) to form a new stabilized complex, which functions as a transcriptional activator.  
Early research focused on canonical Notch transcription targets such as members of 
the Hes and Hey families, but the study of these targets alone is not enough to cover all 
the regulatory effects of Notch. Therefore, an increasing number of studies have started 
to reveal non-canonical Notch transcription targets such as myc and fabp4 to expand the 
scope of transcriptional regulation by Notch (Harjes, Bridges, McIntyre, Fielding, & 
Harris, 2014; Palomero et al., 2006). In addition, the continuous exploration of the 
regulatory potential of CSL is another key to deepening our understanding of the Notch 
pathway and its role in human health and disease. 
Early research on Notch was limited to canonical pathways, meaning that although 
each Notch receptor has their own structural differences, their functions are generally 
considered to be mutually redundant because Notch receptors activate the same CSL 
complex. However, increasing evidence has proven that each of the four Notch receptors 





Notch receptors and CSL complex may be not enough to explain the unique role of Notch 
receptors in development and disease. 
 
1.3.3 The activation of Notch receptors 
Since signaling amplification has not been observed in the study of the canonical 
Notch pathway, the role of Notch remains highly determined by the method of activation, 
typically the ligand-receptor interaction. However, due to the differences in ligands and 
the different ways in which ligands bind to a given receptor, the activation of the Notch 
signaling cascade is a highly complex process (Figure 1-4) (Bray, 2016). 
Trans-activation  
Trans-activation of the Notch pathway refers to the interaction of Notch receptors 
with canonical ligands on neighboring cells (Figure 1-4 A). When a Notch ligand and a 
receptor are respectively expressed in adjacent cells, the ligand on the signal-sending cell 
specifically binds to the Notch receptor located on the surface of the signal-receiving cell. 
The signal-sending cell then pulls the ligand-receptor complex by endocytosis to expose 
the cleavage sites of the receptor to the ADAM metalloprotease and the γ-secretase. Since 
the physical force on the receptor is the key for subsequent cleavage events, simple 
ligand-receptor binding does not activate the pathway but instead inhibits the pathway by 
occupying the receptor. For instance, in vitro experiments showed that the addition of 
Jagged1 only activated the Notch pathway when Jagged1 was present and physically 
attached to the culture dishes, whereas it appeared to inhibit Notch activity when Jagged1 






The cis-binding of the Notch receptor and canonical ligand has been reported in 
cases where both the ligand and receptor are expressed by the same cell (Figure 1-4 B). 
Because the direction is opposite to that of trans-binding, the endocytosis of the ligand 
cannot provide a pulling force to the receptor, resulting in an inactivated receptor. In 
addition, it has been hypothesized that the trans- and cis-binding sites overlap, and the 
cis-interaction has higher affinity so that cis-bound ligand-receptor complexes are stable 
enough to block the trans-activation.  
Interactions with non-canonical Notch ligands 
As described, non-canonical Notch ligands, Dlk1 and Dlk2, are not cell bound so 
that these two ligands have similar roles to soluble canonical ligands (Figure 1-4 C). The 
complex formed with a Notch receptor and non-canonical ligand does not generate 
cleaved NICD because there is no force to expose the cleavage site of the Notch receptor. 
In other words, Dlk1 and Dlk2 are negative regulators of Notch. It is reported that Dlk1, 
also known as preadipocyte factor 1 (Pref1), inhibits cell lipid synthesis by binding to and 






Figure 1-4: Interactions of Notch receptors and ligands. A. Receptors and ligands 
expressed in different cells release NICD through trans-activation. B. Receptors and 
ligands expressed in the same cell prevent the release of NICD through cis-inhibition. 
C. Non-canonical ligands bind but do not activate receptors. 
 
1.4 Notch and Adipogenesis 
1.4.1 Notch pathway and adipogenesis 
 The negative effect of the Notch pathway on adipogenesis has been demonstrated 
by multiple studies across different cell lines. For instance, it has been reported that the 
inhibition of Notch using a  -secretase inhibitor (GSI) promoted adipogenesis as 
indicated by the increased expression of PPARγ and accumulation of lipid vesicles in 
BMSCs, hADSCs, and mADSCs (Huang et al., 2010; Osathanon, Subbalekha, 





Clements, 2007). On the other hand, the activation of Notch was also triggered by the 
overexpression or tissue culture dishes coated in Notch ligand Jagged1. Finally, 
suppressed adipogenesis was also observed in hADSCs, hBMSCs, and 3T3-L1 
preadipocytes (Osathanon et al., 2012; Ross, Rao, & Kadesch, 2004). Therefore, multiple 
in vitro studies have provided a consensus for the negative role of Notch in adipogenesis. 
 
1.4.2 Canonical regulation of Notch to adipogenesis 
Hes1 and adipogenesis 
In order to gain a deeper understanding of the mechanism by which Notch inhibits 
adipogenesis, several Notch canonical targets such as Hes1 and Hey1 have become the 
primary subject of on-going research. Indeed, Hes1 has been demonstrated to suppress 
adipogenesis by blocking the transcription of ppar (Herzig et al., 2003). Since PPAR is 
essential for fat differentiation, early research suggested that Hes1 was the key molecule 
for Notch to inhibit adipogenesis, and additional experiments were conducted to 
determine the relationship between Notch receptors, Hes1, and PPAR However, 
subsequent research has revealed that the role of Hes1 in adipogenesis is more 
complicated than originally proposed. 
First, the expression of Hes1 is not sensitive to the activity of Notch during 
adipogenesis. Indeed, Notch is not the only regulator of Hes1 since it has been reported 
that the transcription of hes1  is also regulated by the Stat3-Socs3 complex, as well as 
Hedgehog and Wnt signaling pathways (Kageyama, Ohtsuka, & Kobayashi, 2008; Rani, 
Greenlaw, Smith, & Galustian, 2016). More importantly, Hes1 also represses its own 





Therefore, in early differentiation, the transcription of hes1 remains at the basal level 
until a strong signal appears later in the differentiation process to drive enhanced 
expression (Scroyen, Bauters, Vranckx, & Lijnen, 2015). As a consequence, neither the 
treatment of DAPT nor a knockdown of Notch3 further reduces the expression of Hes1, 
and in fact, the overexpression of Notch4 appears capable of elevating Hes1 expression 
(Lai et al., 2013; Scroyen et al., 2015).  
Besides the weak response of Hes1 to the Notch signaling pathway during 
adipogenesis, the negative correlation between Hes1 and PPAR was not consistently 
reported. Although Herzig et al. demonstrated that Hes1 suppressed adipogenesis by 
blocking the transcription of ppar (Herzig et al., 2003), Ross and his colleagues found 
that the expression of PPAR was decreased whether Hes1 was overexpressed or 
knocked down in 3T3-L1 cells, suggesting dual roles of Hes1 in the expression of 
PPAR during adipogenesis (Ross et al., 2004). Subsequent studies have also reported a 
weak correlation between Hes1 and PPAR. For example, the overexpression of NICD4 
was shown to increase the expression of both Hes1 and PPAR in 3T3-L1 preadipocytes 
during in vitro adipogenesis (Lai et al., 2013). For in vivo studies, the Ad-NICD mouse 
model with adipocyte-specific overexpression of NICD1 was established, and increases 
in the expression of Hes1 in both inguinal WAT (iWAT) and epididymal WAT (eWAT) 
were observed (Bi et al., 2016; Chartoumpekis et al., 2015). However, the transcription of 
pparγ decreased in iWAT, but not eWAT (Chartoumpekis et al., 2015), while a random 
variation in the protein level of PPARγ in eWAT of Ad-NICD mice was observed (Bi et 
al., 2016). What is more interesting, is that compared to iWAT, eWAT was more affected 





mice aged until it almost disappeared in 3-month old Ad-NICD mice (Bi et al., 2016; 
Chartoumpekis et al., 2015). Therefore, it seems that Hes1 is not the only path for Notch1 
to regulate the expression of PPAR in mature adipocyte lipid regulation. 
Indeed, the final transcription suppressive effect on pparγ not only depends on the 
expression but also the activity of Hes1. Hes1 binds and suppresses the transcription of 
target genes after dimerization, a process known as active suppression. Again, Hes1 
blocks the transcription of pparγ at the E-box in the promoter region (Herzig et al., 2003). 
However, different from other basic helix-loop-helix (bHLH) transcriptional repressors, 
Hes1 has higher preference for the N-box rather than the E-box motif (Sasai et al., 1992), 
suggesting that the inhibitory effect of Hes1 on pparγ is not as high as that of other 
targets containing N-boxes. Since the transcription of pparγ is regulated by multiple 
cascades, the preferential inhibition of these targets may result in the final increase of 
pparγ. On the other hand, different patterns of dimerization also determine the affinity of 
Hes1 for target sequences. For instance, the heterodimer of Hes1 and Hey1 exhibits a 
higher affinity for target sequences than the homodimer of Hes1 itself (Iso et al., 2001). 
Therefore, the effect of Hes1 active repression on pparγ remains unclear. On other hand, 
Hes1 is capable of indirectly inhibiting the transcription of genes with E-boxes by 
competing for activator‐type bHLH factors such as E47, a process referred to as passive 
repression (Kageyama et al., 2008). However, whether the passive repression is involved 
in the regulation of PPAR has not yet been reported. In conclusion, both expression and 
activity of Hes1 are highly dynamic during adipogenesis, and more in-depth studies are 
required to fully discover the role and importance of Hes1 in the regulation of Notch 





Hey1 and adipogenesis 
Hey1 is another canonical Notch target that has been studied in adipogenesis. 
Different from Hes1, the expression of Hey1 constantly increases as adipogenesis 
progresses (Scroyen et al., 2015). It has been reported that the transcription of hey1 can 
be directly activated by the BMP9-SMAD1/5 cascade (Wöltje, Jabs, & Fischer, 2015), 
and the activation of TGF-β-SMAD3/4 cascade also transiently activates the transcription 
of hey1 in a Notch-inhibited condition (Zavadil, Cermak, Soto-Nieves, & Böttinger, 
2004). On the contrary, as a target of the Wnt/-catenin signaling pathway, COUP 
transcription factor 2 (COUP-TFⅡ) blocks the transcription of ppar while also 
suppressing the transcription of hey1 (Scroyen et al., 2015). Therefore, after the initiation 
of adipogenesis, the activation of the BMP cascade and the down-regulation of COUP-
TFⅡ simultaneously lead to the increase in the transcription of hey1 (Scroyen et al., 
2015). However, Hey1 was positively correlated with the transcription of ppar, and no 
further data has indicated the mechanism behind this observation. Therefore, Hey1 is 
another target that may explain the inhibition of Notch during adipogenesis. 
 
1.4.3 Non-canonical regulation of Notch to adipogenesis 
Notch receptors and PPAR 
The inhibitory role of Notch in adipogenesis was mostly determined by altering 
the activity of Notch receptors. As upstream molecules of the Hes and Hey families of 
transcription factors, Notch receptors may regulate the expression of PPAR through 
other pathways. In other words, investigating the role of non-canonical Notch pathways 





signaling regulates cell behavior. Although there is no detailed mechanism yet reported, 
Nueda et al. compared the effects of different Notch receptors in 3T3-L1 preadipocytes 
on PPAR  during adipogenesis. They observed an increase in the transcription of 
ppar with the overexpression of full-length Notch1 but a decrease in ppar transcription 
when any of the other three Notch receptors were overexpressed, suggesting that Notch1 
might promote the expression of PPAR while other Notch receptors inhibit this 
expression (Nueda et al., 2018). To date, there is no literature on the role of Notch2 
during adipogenesis and limited research on Notch4 indicating a need for additional 
research to uncover the mechanism through which each of the Notch receptors is 
involved in adipogenesis.  
Most of the research to date has focused on Notch1, where several in vitro studies 
suggest a positive correlation between Notch1 and PPAR in 3T3-L1 and C3H10T1/2 
cells during adipogenesis (Garcés et al., 1997; Nueda et al., 2018; Song et al., 
2016) However, since only transcription data of pparγ was reported in those studies, it is 
difficult to determine whether changes in Notch1 are capable of affecting PPAR at the 
protein level. Similar outcomes have also been observed through in vivo studies. Two 
similar Adipoq-Cre/RosaN1ICD (Ad-NICD) mouse models were established to have 
adipocyte-specific overexpression of NICD1. However, a random variation in the 
expression of PPAR was shown in the WAT from different individual mice (Bi et al., 
2016; Chartoumpekis et al., 2015). Given the minimal amount of data and some 
contradictory findings through in vivo studies, the relationship between Notch1 and 





However, more has been learned through the use of in vitro studies where Notch1 
appears to promote lipid accumulation during adipogenesis, while the adipoq-Cre 
induced overexpression of NICD1 caused lipodystrophy and dedifferentiation in Ad-
NICD mice (Bi et al., 2016; Chartoumpekis et al., 2015; Garcés et al., 1997). To answer 
this, Bi and his colleagues further reported that the dimerization of PPAR and its ligand 
was obstructed in NICD1-overexpressed WAT (Bi et al., 2016). However, given that 
adiponectin is one of adipokines secreted by mature WAT, the overexpression of NICD1 
driven by adipoq (the gene encoding adiponectin) only happens after late adipogenesis. 
In brief, the function of Notch1 is not fully exerted throughout the process of fat tissue 
differentiation. Moreover, since the overexpression of NICD1 further induced insulin 
resistance in Ad-NICD mice, it is difficult to determine whether the obstructed activation 
of PPAR is the endogenous cause of lipodystrophy or just a consequence of an insulin 
resistance-induced decrease in energy metabolism. Therefore, the correlation between 
Notch1 and PPAR activity during in vitro adipogenesis requires more research to 
confirm. 
Given that C/EBP and PPAR activate the transcription of each other during 
adipogenesis, the varied activity of PPAR may cause a change of its own transcription. 
On the other hand, since the free long-chain fatty acids (LCFAs) are endogenous ligands 
of PPARs, both expression and activity of PPAR may be affected by the variation of 
lipid storage during adipogenesis (Nakamura, Yudell, & Loor, 2014). Therefore, it is 
worth further investigation to discover the relationship between Notch receptors and 
other adipogenesis related molecules as Notch may also determine the final expression of 





Notch1 and Srebp-1c 
The sterol regulatory element-binding protein 1c (Srebp-1c) is one of the early 
adipogenic markers and is the key transcription factor promoting de novo lipogenesis in 
fat, liver, and muscle. The transcription of srebp-1c is activated by mTORC/STAT3 
cascade and that mTORC/Srebp-1c cascade has been accepted as a critical metabolic 
regulator promoting de novo lipogenesis (Ameer, Scandiuzzi, Hasnain, Kalbacher, & 
Zaidi, 2014; Li, Brown, & Goldstein, 2010). As the substrate of the insulin/Akt pathway, 
the activity of mTORC1 is highly sensitive to diet and nutrition (Hay & Sonenberg, 
2004). It has been reported that NICD1 localized to the mitochondria activates the 
mTORC2/Akt pathway in glioma neural stem cells and triple negative breast cancer cells 
(Hossain et al., 2018; Lee et al., 2013), suggesting the possibility that Notch1 activates 
the Akt/mTORC1 cascade in an insulin-independent manner. Indeed, it was also reported 
that liver-specific deletion of Notch1 reduced the stability of mTORC1. On the contrary, 
the activation of Notch1 caused an increased activity of mTORC1 in fatty liver, 
suggesting Notch1 promotes lipogenesis by stabilizing mTORC1 (Pajvani et al., 2013). 
More importantly, since notch1 is also the transcription target of STAT3, the Notch1 
mediated activation of mTORC1 further elevates the level of Notch1 itself through 
STAT3. Therefore, different from the other three Notch receptors, Notch1 is the only 
receptor that is abundantly expressed in the late stage of fat differentiation (Lai et al., 
2013), and this positive feedback loop further promotes the positive regulation of Notch1 
on Srebp-1c. In conclusion, the regulatory impact of Notch1 in mature fat may be much 





Notch Receptors and FABP4 
Fatty acid binding protein 4 (FABP4) is highly expressed in adipocytes and assists 
fatty acid transportation to increase lipid accumulation so that the expression of FABP4 is 
often used as a late adipogenic marker in adipogenesis (Koppen & Kalkhoven, 2010). 
FABP4 is frequently studied as a transcriptional target of PPAR A recent study has 
determined that Notch also activated transcription of fabp4 by activating CSL complex in 
a FoxO1-independent manner (Harjes et al., 2014). Subsequent studies further 
determined that CSL-mediated activation of fabp4 was PPARγ independent (Jabs et al., 
2018). Therefore, the transcriptional activation of fabp4 mediated by PPARγ or Notch is 
two independent events so that any increase in the level of PPARγ or NICDs appears to 
increase the level of FABP4. Indeed, the transfection of any full-length Notch receptors 
increased the transcription of fabp4 in 3T3-L1 cells, while the transcription of pparγ only 
increased in the Notch1-overexpressed group and significantly decreased with the 
overexpression of other three receptors (Nueda et al., 2018). Also interesting is that, 
although the overexpression of Notch1 promoted the transcription of both pparγ and 
fabp4, the fold increase of fabp4 was not as high as it was following the overexpression 
of other three Notch receptors. As mentioned before, LCFAs is positively correlated to 
the expression of PPARγ. However, as a lipid transporter, FABP4 has a much higher 
affinity for LCFAs over PPARγ. Most of LCFAs are esterified in cells, so there is not 
much free LCFAs for the activation of PPARγ and FABP4 (Nakamura et al., 2014). As a 
consequence, the overexpression of FABP4 directly hinders the expression and activity of 
PPARγ by competing with LCFAs. Therefore, the decrease of PPARγ in Notch2-4 





Notch receptors and Lipolysis 
Lipid accumulation depends on the dynamic balance of lipogenesis and lipolysis. 
The relationship between Notch and lipolysis-related molecules has not been well 
defined, but there is still some evidence suggesting that Notch regulates lipid 
accumulation via lipolysis. Forkhead box protein O1 (FoxO1) is an essential transcription 
factor that regulates glycogenolysis and gluconeogenesis in the liver. The transcription 
activity of FoxO1 depends on its phosphorylation status mediated by the insulin/Akt 
pathway. In the case of insulin resistance, the activity of FoxO1 is raised to activate the 
transcription of glucose-6-phosphase (G6pc), resulting in the accelerated release of 
glucose from liver to blood (Pajvani et al., 2011). In addition, the binding site of RBPj, 
a canonical co-factor for Notch signaling, was also found on the promoter region of g6pc. 
Therefore,  the liver-specific loss of both Notch1 and FoxO1 is capable of reducing the 
glucose level by decreasing the transcription of g6pc in liver (Pajvani et al., 2011). 
Similarly, the decrease in the transcription of g6pc was also observed in DAPT treated 
human liver cancer cells (HepG2), indicating that the positive transcriptional role of 
Notch1 in G6pc exists in both in vivo and in vitro cases (N. J. Song et al., 2016).  
However, since subsequent research observed a remission of insulin resistance in Notch1 
deficient antisense transgenic (NAS) mice (N. J. Song et al., 2016), and since elimination 
of G6pc specifically in the liver was insufficient to lower blood glucose (Mutel et al., 
2011), G6pc appears to not be the only target of Notch1 in the regulation of insulin 
resistance. Therefore, the transcription profile of NAS mice was analyzed, and the 
increase in the transcription level of lipid oxidation markers such as PPARα, UCP2, and 





suppresses lipid metabolism through multiple mechanisms (N. J. Song et al., 2016). To 
further confirm this, NICD1 was overexpressed through the transfection of retroviral 
plasmids in HepG2 cells, and the transcription of pparα, ucp2, cpt1 was relatively 
reduced. Briefly, Notch1 appears to promote hepatic lipid accumulation by suppressing 
lipid oxidation in the liver. 
 
1.5 Research motivation and experimental goals 
 
Research on Notch and adipogenesis has been going on for decades, but 
conclusive evidence clarifying its role rarely appears. The main reasons include, but are 
not limited to, the heterogeneity of Notch expression during adipogenic differentiation, 
the different effects of Notch on adipogenesis at different stages, and distinct regulatory 
effects of each Notch receptor in the regulation of adipogenesis. By modulating the 
activation of Notch receptors, Notch is primarily defined as a negative regulator of 
adipogenesis. However, individual receptor focused research has consistently reported 
contradictions. Notch1 is by far the most studied of the four receptors. Some studies 
suggested that Notch1 inhibited adipogenesis by activating Hes1, but more evidence 
showed that Notch1 positively regulated adipogenesis through a non-canonical pathway. 
These opposite statements for the role of Notch make it difficult to accurately define the 
final regulatory effect of Notch1 during adipogenesis. More importantly, the study of 
Notch1 obviously cannot explain the inhibitory effect of Notch on adipogenesis. 





In the remaining receptors, the role of Notch4 has also been initially reported, but 
the effects described are still inconsistent across the literature. Notch2 is often considered 
to behave similarly to Notch1 because of the similarity of their NICDs. Notch3 seems to 
exist independently of these receptors as several studies have reported the unique 
significance of Notch3 in diseases and other aspects of development and human health. 
For example, Notch3 mutations directly lead to Cerebral autosomal-dominant 
arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL), while other 
receptors are not involved in this disease (Machuca-Parra et al., 2017). Therefore, we 
believe that Notch3 in adipogenesis has high research value. In this dissertation, we will 
initially reveal the inhibitory effect of Notch3 on adipogenesis and then explore how 
Notch receptors coordinate with each other by comparing the expression profile and 
localization of Notch3 and Notch1 during adipogenesis. We have contributed to the 
understanding of the biological significance of Notch1 and Notch3 in different stages of 
adipogenesis, which can lead to additional studies and identification of therapeutic targets 






NOTCH3 IS INVOLVED IN ADIPOGENESIS OF HUMAN 
ADIPOSE-DERIVED STROMAL/STEM CELLS 
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is involved in adipogenesis of human adipose-derived stromal/stem cells. Biochimie, 




Adipose-derived stromal/stem cells (ADSCs), are multipotent adult stem cells that 
are able to self-renew and are able to differentiate into a limited number of cells of the 
mesodermal lineage. The secretion profile, immunomodulation, self-renewal, 
multipotency, and homing characteristics of ADSCs make them a useful tool in 
regenerative medicine, organ repair, and cell-based therapies (Gimble et al., 2013; 
Izadpanah et al., 2006; Zuk et al., 2001). Therefore, it is critical that we gain a better 
understanding of the mechanisms that regulate ASC state.  
Derived from lipoaspirates of individuals, adipose stem cells are attractive tools in 
the clinic because they are easy to access and offer therapeutic potential in their 
immunomodulatory and regenerative capabilities. For ADSCs to be qualified for patient 
use they must be (a) expandable ex vivo with high proliferative potentials; (b) possess 
multipotent capability; and (c) must be easy to harvest for autologous transplantation 
(Strem et al., 2005). Because of the vast clinical potential for ADSCs and the role of 





stem cell maintenance and differentiation for safer applications. In addition, the types of 
studies presented here have the potential to uncover genetic mechanisms of disease, 
including in the case of ADSCs, insight into obesity and diabetes. 
The role of stem cells is to aid in the regeneration and repair of various tissues in 
the body. Stem cells are retained in a niche in a balanced state of self-renewing 
multipotency, primed to differentiate when appropriate signals are received (Adam et al., 
2015; Almalki & Agrawal, 2016; Boyer et al., 2005). Minor genetic mutations or 
alterations in the cellular environment may lead to undesired proliferation or 
differentiation resulting in health abnormalities including obesity or cancer. Changes in 
transcription factor expression, signaling pathway activity, genetic mutations, or changes 
in the epigenetic landscape all influence gene expression profiles (Newman & Young, 
2010). Examples of this include early studies where the loss of OCT4 induced 
spontaneous differentiation of embryonic stem cells (Loh et al., 2006), or the 
overexpression of MYOD forced the differentiation of myoblasts to muscle cells (Wei & 
Paterson, 2001). This delicate cell state requires intense regulation in order to maintain 
the health of the individual and so continued investigation of mechanisms that regulate 
cell state to maintain a stem cell niche and drive proper differentiation remains critical. 
Notch signaling is a contact dependent signaling pathway that is conserved across 
all metazoans with a cell-type dependent role in development, niche maintenance, and 
differentiation. Notch is activated when a ligand from the signal sending cell makes 
contact with the receptor from a neighboring cell. This contact triggers two successive 
cleavages of the Notch receptor. The final cleaved product, referred to as the Notch 





activate downstream genes, including the hes and hey family of genes (Andersson, 
Sandberg, & Lendahl, 2011; Gharbiah, Nakamoto, Johnson, Lambert, & Nagy, 2014; E. 
C. Lai, 2002; Miele, 2006; Shi & Stanley, 2006; M. M. Wang, 2011). In the absence of 
active Notch signaling, target genes are bound by co-repressors, which are then replaced 
by the NICD. 
The downstream effect of Notch activation is context dependent as it has been 
shown to be involved in different stages of development, including vascularization and 
angiogenesis (Hirashima, 2009) and myogenesis (Koch, Lehal, & Radtke, 2013; 
Kurpinski et al., 2010; Vasyutina, Lenhard, & Birchmeier, 2007). In adults, Notch 
signaling has been implicated in the maintenance of stem cell niches and directed 
differentiation towards specific lineages (Collesi, Zentilin, Sinagra, & Giacca, 2008; 
Hilton et al., 2008; Kim et al., 2014; Tian et al., 2015; Vujovic et al., 2007; Woo et al., 
2009). 
Multiple studies have shown that Notch signaling promotes the self-renewing 
characteristics of adult stem cells, while inhibition impairs this characteristic (Hilton et 
al., 2008; Moriyama et al., 2014; Tian et al., 2015; Vujovic et al., 2007). However, to 
date the studies on Notch signaling rely heavily on small molecule inhibitors that are not 
specific for a given receptor. Those studies that have investigated the role of Notch3 
specifically have done so primarily in vascularized smooth muscle cells (Baeten & Lilly, 
2015; Domenga et al., 2004). In addition, some recent studies have indicated a role for 
Notch signaling in adipogenesis (Ba et al., 2012; Chartoumpekis et al., 2015; James, 
2013; B. Q. Song et al., 2015) but to our knowledge, there is no study that has evaluated 





the structure of the Notch paralogs are similar, each of the four receptors may have 
distinct functions in different cell types (Shimizu et al., 2002). 
Because the downstream effect of Notch signaling is context dependent and since 
most studies to date have used general -secretase inhibitors, understanding the role of 
specific Notch receptors in ADSCs is necessary for proper characterization and use of 
this stem cell population in the clinic. Here we report a role for Notch3 in regulating 
adipogenesis. Specifically, we demonstrate that a loss of Notch3 does not impact hADSC 
proliferation, but does lead to an increase in adipogenic differentiation, suggesting a role 
for Notch3 in properly directing hADSC differentiation. 
2.2 Materials and Methods 
2.2.1 hADSC Cell Culture 
Human adipose stem cells (hADSCs) were obtained from LaCELL (Lot #412) at 
passage 0. All experiments were performed using cells that had not been passaged more 
than six times. Cells were maintained in complete culture media (CCM) containing MEM 
a (Life Technologies, 12,561-049), 20% fetal bovine serum (Atlanta Biologicals, 
S11550), penicillin streptomycin (Life Technologies, 15,140-122) and L-glutamine (Life 
Technologies, 25,030-081). The cells were maintained in a humidified incubator at 37 ℃ 
with 5% CO2. Cells were stained using trypan blue to establish viability and counted 
using a Countess II FL Automated Cell Counter (Thermo Fisher Scientific, 
AMQAX1000). For experiments assessing proliferation, biological triplicates were 





2.2.2 Notch3 siRNA 
To knockdown notch3，Notch3 small interfering RNA (siRNA) for notch3 was 
used (NOTCH3 Silencer Select siRNA s9641, 4392420). A nonspecific scrambled 
siRNA, Silencer® Select Negative Control No. 1 siRNA, (Thermo Fisher Scientific, 
4390843) was used as a negative control. Cells were seeded at densities of 50,000 
cells/well in a 6 well tissue culture treated plate and 100,000 cells in a 60mmtissue 
culture treated plate. After ADSCs reached 50% confluency, cells were transfected with 
10 nM of siRNA combined with Lipofectamine® RNAiMAX Transfection Reagent (Life 
Technologies, 13778075) and optiMEM (Life Technologies, 31,985-062). After 24 h of 
siRNA treatment, the media was replaced with either complete control media or 
adipogenic differentiation media (LaCell AdipoQual™ Medium, LaADM-500). 
2.2.3 Cell Viability Assay 
A cell viability assay was performed using ReadyProbes® Cell Viability Imaging 
Kit (Blue/Red) (Life Technologies, R37610) following the manufacturer's protocol. 
Images were taken on the EVOS FL imaging system in three different areas for each 
biological sample. Experiments were performed in biological triplicates. Images were 
analyzed using ImageJ software. The counted nuclei of both dead and live cells were 
averaged for each area in the image and the experiment was performed in biological 
triplicate. Three images were taken for each experiment at different locations in the well 
(top, middle, and bottom) with that number being averaged for each individual 






2.2.4 AlamarBlue Assay 
Cell proliferation was measured using an alamarBlue assay (Invitrogen, 
DAL1025) following the manufacturer's protocol. 1500 cells were seeded in a 96 well 
tissue culture treated plate containing 200 mL of complete control media. The cells were 
allowed to attach overnight before being transfected with notch3 or negative control 
siRNA. After 96 h, 20 mL of alamarBlue was added to each well. Fluorescence was read 
at an excitation wavelength of 570 nm and an emission wavelength of 585 nm using the 
BioTek Cytation 5 Take3 plate reader 1 h, 2 h, 3 h, 4 h, and 24 h after addition of the 
reagent. The fluorescence was normalized to a blank well containing only alamarBlue 
reagent and media. Experiments were performed in triplicate and results averaged. 
2.2.5 Adipogenic Differentiation and Oil Red O Staining 
For adipogenic differentiation, complete control media was replaced with 
adipogenic differentiation media 24 h after siRNA transfection. AdipoQual adipogenic 
media was purchased from LaCell. The specifics of media are proprietary, but the media 
does contain ligands for the glucocorticoid and PPAR receptors, the insulin receptor, 
and an agent designed to increase the intracellular level of cAMP. After 14 days in 
differentiation media, with media changes taking place every 72 h, cells were fixed and 
stained, or RNA and protein were collected for gene expression and protein analysis 
respectively. 
Before Oil Red O staining, half of cells in the 60mm dishes were scraped and 
collected with 100 mL RIPA buffer (Santa Cruz, sc- 24948) as shown in Figure 2-3 A. 
The concentration of protein was quantified with Bio-Rad Protein Assay Dye Reagent 





attached cells were fixed in 10% formalin (Azer Scientific, NBF-4-G) for 15 min, washed 
with PBS, and then stained with Oil Red O (VWR, 11,411-412) for 20 min. Images were 
taken at 4x and 10x magnification using a Nikon Eclipse TS100 microscope. The Oil Red 
O was eluted with 60% isopropanol. The concentration of Oil Red O was measured by 
the absorbance of 540 nm light and normalized to the protein concentration previously 
measured. 
2.2.6 RNA Extraction, cDNA synthesis, and qRT-PCR 
To collect RNA from cells, media was aspirated, and wells were rinsed with 
sterile PBS. TRIzol (Life Technologies, 15596018) was added to the well following the 
manufacturer's protocol for RNA extraction. 1 mg of RNA was used for cDNA and was 
synthesized using qScript cDNA Supermix (Quanta Biosciences, 101,414-102) following 
the manufacturer's protocol. qRT-PCR was performed using Power SYBR® Green PCR 
Master Mix (Applied Biosystems, 4367659). All qRT-PCR reactions were performed in 
technical triplicates. GAPDH was used for normalization of qRT-PCR results. All 
primers are listed in Table 2-1. 
Table 2-1: primer table for qRT-PCR 
Gene Name Forward sequence (5’ to 3’) Forward sequence (5’ to 3’) Product 
size (bps) 
gapdh CCCCACTTGATTTTGGAGGGA AGGGCTGCTTTTAACTCTGGT 206 
notch3 CACCCTTACCTGACCCCATCC TTCGGACCAGTCTGAGAGGGA 81 
srebp-1c CTCTTGAAGCCTTCCTGAG GCACTGACTCTTCCTTGAT 138 
ppar GCTGTTATGGGTGAAACTCTG ATAAGGTGGAGATGCAGGTTC 351 
adiponectin TTCCATACCAGAGGGGCTCA GAGTCGTGGTTTCCTGGTCA 89 
fabp4 AAACTGGTGGTGGAATGCGT GCGAACTTCAGTCCAGGTCA 95 
plin2 GCTGAGCACATTGAGTCACG TGGTACACCTTGGATGTTGG 102 







2.2.7 Western Blot 
Cells were rinsed with 1xPBS and collected on cell culture dishes using RIPA 
buffer (Santa Cruz, sc-24948) containing phosphatase and protease inhibitors (Thermo-
Fisher, 78,441). The collection was lysed for 30 min at 4 _C. Cell lysates were removed 
from the dishes and centrifuged in order to isolate protein and remove any cellular debris. 
Protein concentrations were measured using Bio-Rad Protein Assay Dye Reagent 
Concentrate following manufacturer's protocol (Bio-Rad, 500-0006). Protein samples 
were loaded in a 10e15% precast gradient polyacrylamide gel (Bio-Rad, 456e1084). 
Proteins were transferred on a Trans-Blot Turbo Mini PVDF Transfer Pack (Bio-Rad, 
1704156) using the Bio-Rad Trans-Blot Turbo Transfer System. The membrane was 
probed with NOTCH3 rabbit polyclonal antibody (Cell Signaling, 2889s), PPAR mouse 
monoclonal antibody (Santa Cruz, sc-7273), and GAPDH rabbit polyclonal antibody 
(Abcam, ab9485) at 4 _C overnight and incubated with secondary antibody rabbit IgG 
(Abcam, ab6721) or mouse IgG (Abcam, ab6789) for 1 h at room temperature. The 
membrane was visualized with ECL (Bio-Rad, 170e5060). 
2.3 Results 
2.3.1 Notch3 does not Influence hADSC Proliferation 
A defining property of stem cells is their ability to continuously proliferate in an 
undifferentiated state. Therefore, we were initially interested in the role that Notch3 
might play in this process. Notch3 levels were diminished through siRNA-mediated 
transient transfections and efficiency of knockdown was evaluated using qRT-PCR and 
western blot. Significant loss of Notch3 transcript (~70% reduction in transcript) and 





were conducted up to 24 h following a 96 h transfection to monitor changes in 
metabolism and provide a more sensitive and quantitative measure of proliferative 
activity (Figure 2-1 C). The results demonstrate no significant difference in proliferative 
rate, suggesting that Notch3 is not necessary for the maintenance of hADSC self-renewal 
activity. In order to assess viability following a loss of Notch3, a live-dead staining assay 
was conducted 96 h after transfection. The results demonstrate no significant difference 
in live or dead cell count based on a fluorescence assay (Figure 2-1 D), suggesting that 
Notch3 does not have a significant role in cell viability. These results confirm that 











Figure 2-1: Notch3 does not influence viability or cell proliferation of human 
adipose-derived stem cells. A. siRNA knockdown of Notch3 was assessed by qRT-
PCR and B. western blot. qRT-PCR was performed in triplicate. Western blot shows 
biological replicates confirming knockdown. C. Loss of NOTCH3 does not have a 
significant effect on cell proliferation as determined using an AlamarBlue assay. (*P < 
0.05, P value: 0.0442). Error bars denote SE of mean. N=6. qRT-PCR was performed 
in triplicate. Western blot shows biological replicates confirming knockdown. D. Loss 
of NOTCH3 does not affect cell viability 96 h after a transfection as shown by 
viability stain. Live cells are stained with DAPI (P value: 0.835). Dead cells are 
stained with RFP (P value: 0.42). Error bars denote SE of mean. N=3. Live and dead 
cells were counted for stained samples showing no significant difference in the 
number of cells counted for each category. 
 
 
2.3.2 Notch3 Has a Role in Regulating Adipogenesis 
As stem cells are poised between self-renewal and differentiation, we were 
interested to see what role, if any, Notch3 played in regulating adipogenesis of hADSCs. 
Given the ability to easily induce adipogenesis of adipose-derived stromal/stem cells and 





influence of Notch3 on this fundamental biological process. Initially, we looked at levels 
of Notch3 during adipogenesis and found that levels of Notch3 steadily increase during 
the first 14 days of adipogenesis, returning to lower levels 21 days after induction, 
suggesting that Notch3 may have a significant role in the regulation of early adipogenesis 
(Figure 2-2 A). In order to confirm this was also true at the protein level and to ensure 
the transient transfection would work for the length of the designed experiments, 
knockdown was validated with a western blot 11 days after transfection and induction of 
adipogenesis. An increase in Notch3 protein expression 11 days into differentiation was 
observed, corresponding to the qRT-PCR data, and significant knockdown of Notch3 11 
days after a single siRNA transfection confirmed the ability of the transient knockdown 
to persist long enough for proper analysis of differentiation (Figure 2-2 B). 
 
 
Figure 2-2: The transcription of notch3 increases in early adipogenesis. A. Notch3 
transcript levels increase over time up to 14 days after adipogenic induction and then 
return to levels close to that observed in undifferentiated hASCs by 21 days after 
induction of adipogenesis. Statistical analysis comparing Notch3 expression during 
differentiation to the undifferentiated control. *P< 0.05, **P<0.01, N=3. B. Protein 
analysis confirms an increase in Notch3 expression 11 days after induction of 
adipogenesis compared to undifferentiated cells and also demonstrates efficiency of 







To determine the role of Notch3 in adipogenesis, cells were stained using Oil Red 
O to monitor formation of lipid vesicles and RNA was collected to measure expression of 
adipogenic gene markers. Morphology, imaging, quantification of Oil Red O staining, 
and expression of PPAR, along with ppar and srebp1c transcript, confirm an increase 
in adipogenesis following the loss of Notch3 (Figure 2-3 A, B, and C). These results 
were further confirmed by analyzing transcript levels of adipogenic gene markers 7 days 
after knockdown and induction of adipogenesis. A significant increase in expression of 
adiponectin, fabp4, and plin2, with a similar trend observed for lpl further supporting the 
increase in adipogenesis following the loss of Notch3 (Figure 2-3 D). By tracking 
differentiation in the absence of Notch3, we conclude that Notch3 is involved in the 
regulation adipogenesis and speculate that it may have a role in inhibiting adipogenesis 






Figure 2-3: Loss of Notch3 leads to increased adipogenesis. A. Oil Red O staining 
indicates an increase in lipid vesicle formation. This is shown by images of stained 
plates (left), microscopic images (middle), and quantification of stain normalized to 
total protein present in control and knockdown conditions. *P< 0.05. N=3. B. Protein 
analysis confirms knockdown of Notch3 in cells undergoing adipogenesis after 14 
days and validates increase in adipogenesis by showing an increase in PPARg protein 
expression. C. qRT-PCR confirmed increased adipogenesis after 14 days of induction 
with significant increases in transcript for pparg and srebp1c. D. Additional markers 
of adipogenesis were tested and further confirmed the impact that loss of Notch3 







The delicate balance maintained by stem cells between a self-renewing and 
differentiating cell state requires tight control of transcription where cells are primed to 
respond to specific signaling cascades responsible for promoting and inhibiting paths of 
differentiation. The results presented here help to clarify the role of Notch signaling in 
adult stem cells by investigating a single receptor, rather than using a more general 
pathway inhibitor. Here we show, using siRNA-mediated knockdown, that the loss of 
Notch3 is not lethal to the cells and does not impact hADSC self-renewal, but does have 
an impact on adipogenesis. Specifically, the loss of Notch3 leads to an increase in 
adipogenesis suggesting that Notch3 functions to regulate this lineage commitment when 
present at wildtype levels. Earlier literature using a g-secretase inhibitor of Notch 
signaling indicates an increase in adipogenesis of mouse adipose-derived stem cells by 
promotion of PPAR expression (Huang et al., 2010). Our study isolates Notch3 and 
suggests that at least this receptor, on its own, may have a significant impact in regulating 




Previous studies have shown a role for Notch signaling in adipogenesis, including 
identification of Notch1 in the regulation of metabolism and the generation of brown 
adipose tissue (Bi & Kuang, 2015; Bi et al., 2014). By linking a second Notch receptor to 
the regulation of adipogenesis, we have identified another potential target for the 





accelerated conversion of ADSCs into adipocytes, offering a potential explanation for 
uncontrollable weight gain and a novel genetic marker for obesity. In addition, these 
findings help to identify pathways that can be examined and targeted in individuals to 
anticipate potential side effects of stem cell transplants. With this data, we propose a 
model where Notch3 may inhibit adipogenesis in ADSCs, helping to maintain a proper 
balance of adipose stem cell state. In the absence of Notch3, gene expression is altered, 
and proper breaks are lost, leading to an increase in adipogenesis compared to cells with 
normal levels of Notch3. Additional research will be necessary to determine the role of 
each of the other three Notch receptors, overlap in function, and compensatory roles in 
the case of a receptor mutation in each of these developmental cascades in order to better 






DISTINCT ROLES OF NOTCH1 AND NOTCH3 IN HUMAN 
ADIPOSE-DERIVED STROMAL/STEM CELL ADIPOGENESIS 
Under Review: Liu M, Logan H, Newman J.J. (2020). Distinct Roles of Notch1 
and Notch3 in human adipose-derived stromal/stem cell adipogenesis. Stem Cell 
Reviews and Reports. 
 
3.1 Introduction 
Obesity and obesity-related diseases are an ever-growing health concern.  The 
symptoms associated with obesity are in part related to the formation and accumulation 
of adipose tissue that leads to inflammation and alters metabolism (Ghaben & Scherer, 
2019).  In order to better understand how obesity contributes to compounding health 
concerns and identify potential therapeutic targets to curb these downstream affects, there 
must be further investigation of the mechanistic process that drives and regulates 
adipogenesis.  
The increase in adipocytes in adults depends on the rate and regulation of 
adipogenesis of both precursors and human adipose-derived stem/stromal cells 
(hADSCs). hADSCs are a type of mesenchymal stem cell with the ability to self-renew 
and differentiate into multiple types of cells from the mesoderm germ layer (Si et al., 
2019). Continuous research has shown that in a specific in vitro environment, hADSCs 
can overcome the natural barriers of their multipotency and differentiate into non-





regeneration (Radtke, Schmitz, Spies, Kocsis, & Vogt, 2009; Timper et al., 2006). In 
addition, it has been observed that hADSCs display low antigenicity and strong 
immunosuppressive effects leading them to receive extensive attention as a potential cell-
based therapeutic (Traktuev, Parfenova, Tkachuk, & March, 2006). Despite the 
tremendous potential, the clinical use of hADSCs has been limited due to the lack of 
knowledge surrounding the molecular mechanisms that regulate and determine cellular 
properties and behavior. 
Several factors contribute to the properties and cell fate determination of 
hADSCs, including the physical environment and endogenous signaling cascades that 
lead to downstream changes in gene expression profiles.  Notch signaling is a critical 
contact-dependent developmental signaling pathway that is involved in cell fate 
determination and human development. In addition, Notch has been implicated in 
differentiation, proliferation, metabolism, and tumorigenesis (Giuli, Giuliani, Screpanti, 
Bellavia, & Checquolo, 2019; Hossain et al., 2018; Meurette & Mehlen, 2018; Osathanon 
et al., 2012). Indeed, the Notch pathway has also been largely accepted as a negative 
regulator of adipogenesis in both in vivo and in vitro based studies that use γ-secretase 
inhibitors to inhibit pathway activity (Huang et al., 2010; Osathanon et al., 2012; B. Q. 
Song et al., 2015; Vujovic et al., 2007). However, when studies are performed to identify 
the function of individual Notch receptors during adipogenesis, the role of the Notch 
signaling pathway becomes less clear. In in vivo studies, the forced overexpression of the 
Notch1 intracellular domain (NICD1) leads to lipodystrophy or dedifferentiation in 
various transgenic mouse models (Bi et al., 2016; Chartoumpekis et al., 2015).  However, 





lipid accumulation when fed a high fat diet (N. J. Song et al., 2016). Similar 
contradictions are also observed in in vitro studies. For example, an siRNA-mediated 
Notch1 knockdown significantly reduces the expression of PPARγ in 3T3-L1 and 
C3H10T1/2 cells (N. J. Song et al., 2016), and the overexpression of full-length Notch1 
is capable of increasing the transcription of PPARγ in 3T3-L1 cells (Nueda et al., 2018). 
In contrast, Notch1 appears to play a negative role in adipogenesis in Rosiglitazone-
induced thymic stromal cells (Y. Wang et al., 2018). Taken together then, the stable 
inhibitory effect of Notch on adipocyte differentiation is complicated and cannot be fully 
attributed to Notch1. Indeed, the role of the Notch pathway during adipogenesis also 
relies on the other three receptors. To better understand how these four receptors work 
independently, we previously reported that the knockdown of Notch3 increases 
adipogenesis in hADSCs (Sandel et al., 2018).  These finding were confirmed by studies 
performed by Nueda et al. that demonstrated a decrease in the transcription of PPARγ in 
3T3-L1 cells transfected with full-length Notch3 (Nueda et al., 2018). Despite these 
findings, the mechanism for how Notch signaling regulates cell fate during adipogenesis 
remains unclear.  
With this study we sought to determine the relationship between Notch1 and 
Notch3 to clarify ambiguity in the literature and have a better understanding for how the 
Notch pathway regulates adipogenic differentiation of hADSCs. We observed high levels 
of Notch3 in un-differentiated hADSCs where it appears to function as a suppressor of 
adipogenesis, while the expression of Notch1 rose dramatically following the visible 
formation of lipid vesicles. In addition, unlike Notch3, Notch1 was absent from the 





canonical Notch1 cascade. Furthermore, we found that Notch3 was capable of 
suppressing adipogenesis in a Hes1/Hey1-independent manner and instead may maintain 
the stem cell state of hADSCs by activating the canonical Wnt/β-catenin signaling 
pathway during early adipogenesis.  Together these observations provide new insights 
into the role of specific Notch receptors during adipogenesis and introduce mechanisms 
of crosstalk between signaling pathways, creating the possibility for novel therapeutic 
targets in the fight against obesity and metabolic-related disease. 
 
3.2 Materials and Methods 
3.2.1 Cell Culture 
Human ADSCs (AA20181218, P0) purchased from Obatala, Inc. Cells were 
cultured in MEM-α (12571048, Thermo Fisher Scientific) supplemented with 1% 
Pen/Strep (15140122, Thermo Fisher Scientific), 1% L-Glutamine (25030081, Thermo 
Fisher Scientific), and 16% fetal bovine serum (s11550, Atlanta Biologicals) at 37℃ and 
5% CO2 until 70-80% confluent. Cells were then detached using 0.25% Trypsin 
(25200056, Thermo Fisher Scientific) and seeded onto tissue culture dishes (10 cm for 
protein assays, 6-well for RNA assays, and 24-well for cell morphology assays) at the 
same cell density of 1,667 cells/cm2. Media was replaced every 48 hours. All experiments 
were performed with cells that had been passaged no more than three times to ensure 
maintenance of stem cell properties. 
3.2.2 Knockdown Studies 
At 50% confluency, cells were transfected with scrambled (AM4611, Thermo 





Fisher Scientific), RBP-Jκ- (s223923, Thermo Fisher Scientific), or β-catenin-specific 
siRNA (s146154, Thermo Fisher Scientific) using RNAi Max Lipofectamine (13778075, 
Thermo Fisher Scientific) and Opti-MEM (31985062, Thermo Fisher Scientific) 
following manufacturer’s protocol. Specifically, when double-knockdowns were 
performed in the experimental group, the same concentration of scrambled siRNA was 
added in the single target knockdown group to ensure the same concentration  of 
transfected siRNA, and at the same time, the amount of RNAi Max Lipofectamine  was 
doubled accordingly to ensure the consistency among groups. Cells were then incubated 
at 37℃ and 5% CO2 for 24 hours before the induction of adipogenesis using AdipoQual 
adipogenic induction media purchased from Obatala Sciences, Inc. Media was changed 
every 72 hours.  
 
3.2.3 RNA Isolation and qRT-PCR 
Total RNA was collected with TRIzol Reagent (15596018, Thermo Fisher 
Scientific) and subsequently extracted with chloroform following the manufacturer’s 
protocol. The concentration of RNA was quantified based on the absorbance at 260 nm 
and cDNA was synthesized using 1000ng of RNA and qScript cDNA SuperMix 
(101414106, Quantabio). PowerUp SYBR Green Master Mix (A25742, Thermo Fisher 
Scientific) was used to perform qRT-PCR on a StepOnePlus real-time PCR system 
(Thermo Fisher Scientific) following the manufacture’s protocol. Relative transcription 
levels were normalized to GAPDH and fold change was calculated using the ΔΔCt 
method.  Primers were designed and optimized prior to use in qRT-PCR (Table 3-1).  All 





for each qRT-PCR reaction. The error bars represent standard error, and p-values were 
calculated using a student t-test. 
Table 3-1: Sequence of primers. 
Gene 
Name 
Forward sequence (5’ to 3’) Forward sequence (5’ to 3’) Product 
size (bps) 
gapdh ACTAGGCGCTCACTGTTCTCT CAATACGACCAAATCCGTTGACT 99 
notch1 CACGCTGACGGAGTACAAGT GGCACGATTTCCCTGACCA 56 
notch3 CACCCTTACCTGACCCCATCC TTCGGACCAGTCTGAGAGGGA 81 
hey1 TGAGCTGAGAAGGCTGGTAC ATCCCAAACTCCGATAGTCC 170 
hes1 AAAAATTCCTCGTCCCCGGT GGCTTTGATGACTTTCTGTGCT 98 
pparγ AGGATGCAAGGGTTTCTTCCG TGGGCGGTCATTATGAGACAT 157 
ctnnb1 ACAATGGCTACTCAAGGCTACC GCTCCAGAAGCAGTCATCCA 117 
 
 
3.2.4 Protein Extraction and Western Blot 
Total protein and nuclear protein were extracted with Pierce RIPA buffer (89900, 
Thermo Fisher Scientific) and NE-PER Nuclear and Cytoplasmic Extraction Reagents 
(78833, VWR), respectively.  In both cases, Halt Protease & Phosphatase Inhibitor 
Cocktail (78441, Thermo Fisher Scientific) was added to the buffer prior to treatment of 
cells. Protein concentration was quantified using a BSA based Bradford assay (5000006, 
Bio-Rad).  
70 ng of total protein or 30 ng of nuclear protein was added to Laemmli Sample 
Buffer (1610737, Bio-Rad) and boiled in a water bath for five minutes. Denatured 
samples were loaded in a 4-15% Mini-PROTEAN TGX Gels (4561084, Bio-Rad) and 
separated by electrophoresis before being transferred to a PVDF membrane (88518, 
Thermo Fisher Scientific). The membrane was incubated with blocking buffer made up 
of TBST (Tris Buffered Saline with 0.1% Tween 20) containing 5% w/v of non-fat milk 





antibodies (Table 2) were added to the blocking buffer and membranes were incubated at 
4℃ overnight. The probed membrane was washed with TBST three times and probed 
with the corresponding secondary antibody (Table 3-2) and Precision Protein 
StrepTactin-HRP Conjugate (1610308, Bio-Rad) at room temperature for one hour. 
Membranes were washed with TBST three times and then covered with Clarity Western 
ECL Substrate (1705060, Bio-Rad). Images was captured with the ChemiDoc Touch 
Imaging System (Bio-Rad). The enrichment of each protein target was quantified using 
ImageJ and normalized to GAPDH for total protein and TBP for nuclear protein. 
Table 3-2: Antibodies for western blot 
Name of Primary Antibodies Catalog # Vendor Concentration 
GAPDH Ab9485 Abcam 1:3000 
Notch1 (C-20) Sc-6014R Santa Cruz Biotechnology 1:1000 
Notch3 2889 Cell Signaling Technology 1:1000 
Hes1 (EPR4226) Ab221788 Abcam 1:1000 
Hey1 Ab22641 Abcam 1:1000 
RBPSUH (RBP-Jκ) 5313 Cell Signaling Technology 1:1000 
Dlk (B-7) Sc-376755 Santa Cruz Biotechnology 1:1000 
Lamin B1 (A-11) Sc-377000 Santa Cruz Biotechnology 1:1000 
PPARγ (E-8) Sc-7273 Santa Cruz Biotechnology 1:1000 
PPARγ (C26H12) 2435 Cell Signaling Technology 1:1000 
TBP Ab125009 Abcam 1:1000 
GSK3β (27C10) 9315 Cell Signaling Technology 1:1000 
P-GSK3β (S9) 5558 Cell Signaling Technology 1:1000 
Non-P β-catenin (D13A1) 8814 Cell Signaling Technology 1:1000 
 
Secondary Antibodies Catalog # Vendor Concentration 
Goat Anti-Mouse IgG (HRP) Ab6789 abcam 1:1000 
Goat Anti-Rabbit IgG (HRP) Ab6721 abcam 1:1000 
 
 
3.2.5 Co-Immunoprecipitation (Co-IP) 
Co-immunoprecipitations were performed using the Pierce Crosslink Magnetic 
IP/Co-IP Kit following the manufacturer’s protocol. Specifically, 2x106 cells were used 





Thermo Fisher Scientific) was used throughout protein purification and storage. To 
isolate Notch3, the combination of anti-Notch3-2889 (Cell Signaling Technology) and 
anti-Notch3-5276 (Cell Signaling Technology) was used; to pull down β-catenin, the 
combination of anti- β-catenin (B-9) (Santa Cruz Biotechnology) and anti- β-catenin 
(D10A8) (Cell Signaling Technology) was used (4 µl for each antibody). Normal Rabbit 
IgG-2729 (Cell Signaling Technology) was used for the negative control pull-down 
sample (Mock). To minimize the background and detection of antibodies, SDS reducing 
sample buffer (39000,  Thermo Fisher Scientific) was used for protein denaturation, and 
1:1000 v/v of Mouse Anti-Rabbit IgG-HRP (5127s, Cell Signaling Technology) was used 
as a secondary antibody for western blot. 
3.2.6 Immunofluorescence Staining 
Cells were fixed with 10% neutral buffered formalin for 20 minutes at 4℃ and 
washed three times with PBS. Fixed cells were incubated with permeabilization buffer 
(PBS with 0.2% Triton X-100) for five minutes and subsequently submerged with Image-
iT FX Signal Enhancer (i36933, Thermo Fisher Scientific) for 45 minutes at room 
temperature. After three washes with PBS, 1:100 v/v anti-Notch1 (Sc-6014R) or anti-
Notch3 (2889) was added to the blocking buffer (PBS supplied with 1% BSA, 0.05% 
Tween 20, and 0.2% Triton X-100) and samples were incubated overnight at 4℃. Fixed 
cells were washed three times with blocking buffer prior to the addition of secondary 
Goat Anti-Rabbit IgG H&L Alexa Fluor 555 (ab150078, abcam), ActinGreen 488 
ReadyProbes reagent (R37110, Thermo Fisher Scientific), and DAPI (62248, Thermo 





respectively. After one hour at 4℃, cells were washed twice with blocking buffer and 
once more with PBS prior to imaging with an EVOS Fluorescence Microscope. 
 
3.3 Results 
3.3.1 Notch1 and Notch3 are Uniquely Expressed during Adipogenesis 
It is generally accepted that signaling pathways have redundancy to prevent the 
significant impact that changes to a single receptor may have on a cell.  Given that the 
Notch pathway has four receptors, we first wanted to determine if an individual receptor 
had a unique role in adipogenesis.  If the pathway were redundant, then the knockdown 
of a single receptor would not cause a phenotypic change or impact the differentiation of 
hADSCs.  We initially monitored the expression of Notch1 and Notch3, two highly 
characterized receptors of the Notch pathway, over a 21-day period of adipogenic 
differentiation.  Both mRNA and protein indicated that the level of Notch3 increased 
rapidly in the first 72 hours of adipogenic differentiation and diminished quickly after 
that, while the expression level of Notch1 did not increase until five days after the 
induction of adipogenesis (Figure 3-1). This temporal regulation during differentiation 








Figure 3-1: Notch1 and Notch3 are differentially expressed during adipogenesis. (A) 
The relative levels of expression for Notch1 and Notch3 were measured with qRT-
PCR in hADSCs cultured with adipogenic media for 21 days. N=3, *p< 0.05, **p< 
0.01. (B) Activated forms of Notch1 (NICD1) and Notch3 (NICD3) were detected by 
western blot using protein lysate collected at various time points from hADSCs 
cultured in adipogenic media for 21 days. (C) Relative levels of NICD1 and NICD3 
from the western blot quantified using ImageJ software and normalized to GAPDH. 
Furthermore, we observed morphological changes during adipogenesis indicating 
that lipid droplet formation begins four days after the induction adipogenic 
differentiation. This corresponded with the observed decrease in Notch3 expression and 
simultaneous increase in Notch1 expression.  Therefore, we hypothesized that Notch1 
and Notch3 are uniquely expressed in cells during different stages of differentiation. To 
support this, we performed immunofluorescence (IF) which indicated that Notch1 was 
highly expressed in cells that had synthesized lipid vesicles with the expression level of 
Notch1 increasing as adipogenesis progresses (Figure 3-2 A, left).  Notch3, however, 
was exclusively expressed in those cells newly committed to adipogenic differentiation 





we believe that the overall increase of Notch1 and the decrease of Notch3 over time may 
be the result of increased differentiation of the overall cell population from multipotent 
hADSCs to preadipocytes (Figure 3-2 D).  
 
Figure 3-2: Notch1 and Notch3 are distinctly expressed in hADSCs at different 
stages of differentiation. (A) The localization of Notch1 and Notch3 throughout 
adipogenesis is shown with immunofluorescence of cells cultured for 5 or 14 days in 
adipogenic media. DAPI was used to stain nuclei, and Phalloidin was used to stain F-
actin filaments. Lipid vesicles are indicated with yellow arrows. Scale bars indicate 
200 µm. (B) The illustration represents a model for the expression profile of Notch1 
and Notch3 during adipogenesis. Notch1 expression increases as the number of 
differentiated hADSCs increases, whereas Notch3 expression diminishes over time as 







3.3.2 Notch3 Plays a Dominant Role in Early Adipogenesis when Compared to 
Notch1 
To determine the potential role for Notch1 and Notch3 during adipogenesis, 
hADSCs were transfected with siRNA targeting each receptor individually and in 
combination. Following transfection of the siRNA, cells were induced to differentiate 
with adipogenic media for six days, at which point RNA and protein were collected for 
analysis. Both transcript and protein expression validated the knockdown of Notch3 and 
indicated a significant increase in Notch1. Conversely, although the knockdown of 
Notch1 was validated with a decrease in the levels of transcript and protein, it did not 
affect the expression of Notch3 even after six days of adipogenic differentiation (Figure 
3-3 A and B). Since the co-expression of Notch1 and Notch3 was not observed in cells 
until nearly five days after the induction of adipogenesis, and even though it was brief 
(Figure 3-2 A), we believe that Notch3 does not directly suppress the expression of 
Notch1. The observed increase in Notch1 expression may instead be the result of an 
increased number of differentiated hADSCs following the Notch3 knockdown, not a 
direct effect of the Notch3 knockdown itself. 
When examining adipogenesis of these samples, both mRNA and protein 
confirmed an increase in the expression of PPARγ in the Notch3 knockdown samples, 
whereas the stable decrease in the protein expression of PPARγ was not observed 
following the knockdown of Notch1 (Figure 3-3 C and D). Finally, a double knockdown 
was also performed, where both Notch1 and Notch3 siRNA were transfected 
simultaneously into hADSCs. An increase in the expression of PPARγ in the double 





knockdown (Figure 3-3 D).  This data further confirms that Notch1 and Notch3 may 
work independently to regulate adipogenesis, and that Notch3 may play a dominant role 
in this process. Together with the expression profiles of Notch1 and Notch3, the data 
suggests that Notch3 may be highly expressed in the early stages of adipogenesis to 
maintain hADSCs in a self-renewing, primed stem cell state, while Notch1 is expressed 














Figure 3-3: Notch1 and Notch3 affect the expression of PPARγ differently during 
adipogenesis. (A) The effects of the Notch1, Notch3, or Notch1-3 double knockdown 
on the transcription of notch1 and notch3 were evaluated using qRT-PCR six days 
after adipogenic differentiation of hADSCs. N=3, *p< 0.05, **p< 0.01.  All data was 
normalized to gapdh. (B) The effects of the knockdown of Notch1, Notch3, or 
Notch1-3 on cleaved Notch1 and Notch3 were assessed by western blot six days after 
inducing adipogenic differentiation of hADSCs. GAPDH was used as the loading 
control for total protein lysate. (C) Relative changes of pparγ1/2 transcripts were 
measured with qRT-PCR following the knockdown of Notch1, Notch3, or Notch1-3 
double knockdown six days after inducing adipogenic differentiation of hADSCs. 
N=3, *p< 0.05, **p< 0.01. Data was normalized to gapdh. (D) The change in PPARγ1 
and 2 protein was assessed by western blot following the knockdown of Notch1, 
Notch3, or the Notch1-3 double knockdown six days after inducing differentiation of 
hADSCs. PPARγ1 is the lower band (50 kDa), and PPARγ2 (55 kDa) is the upper 
band. Lamin B1 was used as the loading control for nuclear protein lysate. In all 
figures, siCtrl indicates samples transfected with negative control siRNA; siN1 and 
siN3 indicate those samples transfected with Notch1 and Notch3 specific siRNA, 
respectively; and siN1+3 indicates those samples transfected simultaneously with both 






3.3.3 Notch1 does not Localize to the Nucleus during Early Differentiation 
Previous studies indicated that the overexpression of NICD1 suppresses the 
expression of PPARγ in white adipose tissues (WAT) by activating the transcription of 
hes1 (Chartoumpekis et al., 2015). However, a consistent change in the expression of 
Hes1 or Hey1 was not observed in our experiments leading us to question the role of the 
canonical Notch1 cascade during in vitro adipogenesis. To develop a better understanding 
of the Notch1 and Notch3 cascades during adipogenesis, IF was performed to determine 
Notch1 and Notch3 localization in hADSCs before and three days after adipogenic 
induction (Day 0 and Day 3, respectively). The level of nuclear NICD1 was significantly 
reduced 72 hours after inducing adipogenesis (Figure 3-4 A), whereas NICD3 was still 








Figure 3-4: Notch1 is absent from the nucleus during adipogenesis. (A) 
Immunofluorescence was used to detect changes in Notch1 localization in hADSCs 
72 hours after inducing adipogenesis. DAPI was used to stain nuclei. Scale bars 
indicate 200 µm. (B) Immunofluorescence was used to detect Notch3 localization in 
hADSCs  hours after inducing adipogenesis. DAPI was used to stain nuclei. Scale 
bars indicate 200 µm.  
 
To obtain a more global view of localization, nuclear protein was isolated at 
various time points over a period of 21 days from cells cultured in adipogenic media. 
Notch3 nuclear protein (NICD3), was observed to be highest during the initiation of 
adipogenesis and diminished within the first five days. Notch1 nuclear protein (NICD1), 





increasing over the three-week period (Figure 3-5 A). The levels of NICD1 and NICD3 
in the nucleus were quantified with ImageJ, and the ratio of nuclear to total protein for 
each receptor was calculated (Figure 3-5 B and C). The data showed that the ratio of 
nuclear NICD3 remained relatively constant at all times. However, the relative amount of 
nuclear NICD1 decreased dramatically at the start of adipogenic differentiation and did 
not rebound until 21 days after the induction of differentiation (Figure 3-5 C). Together, 
this data suggests that Notch1 is not active in the nucleus during adipogenesis, whereas 
Notch3 is still a potential candidate to regulate adipogenesis in a canonical manner. 
 
Figure 3-5: The nuclear localization of Notch1 is limited as adipogenic induction 
initiates. (A) Expression of nuclear NICD1 and NICD3 in hADSCs cultured in 
adipogenic media was determined at different time points using western blot. The 
TATA-binding protein (TBP) was used as a loading control for nuclear protein. (B) 
The protein level of NICD1 and NICD3 from Figure 3C was quantified using ImageJ 
and the relative abundance of each band was normalized to TBP.  (C) The relative 
abundance of NICD1 and NICD3 was subsequently normalized to the relative level of 






3.3.4 The knockdown of Notch3 Promotes Early Adipogenesis of hADSC   
We have previously demonstrated that the knockdown of Notch3 leads to 
increased adipogenesis 14 days after adipogenic induction (Sandel et al., 2018). Given 
the sensitive response of Notch3 to early adipogenic differentiation, mRNA and protein 
of hADSCs were collected before the appearance of lipid drops. Within 72 hours of 
inducing adipogenesis following the knockdown of Notch3, there was an increase in 
transcript and expression of PPARγ1 and a decrease in the expression of Dlk1, a 
preadipocyte marker (Figure 3-6 A and B). Unlike the increase in Notch1 expression 
following the knockdown of Notch3 six days after inducing differentiation of hADSCs 
(Figure 3-6 A and B), after only 72 hours, the level of transcription and the expression of 
the active form of Notch1 decreased (Figure 3-6 C and D). In addition, there was no 
observed change in hes1 expression, although there was an increase in hey1 transcript but 
not protein.  The overall absence of change in Hes1 and Hey1 protein levels suggests that 







Figure 3-6: The knockdown of Notch3 leads to increased adipogenesis independent 
of Hes1/Hey1. (A) Changes of notch3 and pparγ1/2 transcript following the 
knockdown of Notch3 in hADSCs 72 hours after inducing differentiation were 
measured with qRT-PCR. All data was normalized to gapdh. N=3, *p< 0.05, **p< 
0.01. (B) The protein level of Notch3, both full length (FL-Notch3) and cleaved 
(NICD3), Dlk1, and PPARγ1 following the knockdown of Notch3 and 72-hour 
induction of adipogenesis was determined by western blot. (C) The relative levels of 
transcript for Notch signaling components following the knockdown of Notch3 was 
measured with qRT-PCR 72 hours after adipogenic induction. Data was normalized to 
gapdh. N=3, *p< 0.05. (D) The protein level of Notch1, both full length (FL-Notch1) 
and cleaved (NICD1), Hes, and Hey1 following the knockdown of Notch3 and 72-
hour induction of adipogenesis was determined by western blot. In all figures, siCtrl 
indicates samples transfected with negative control siRNA, and siN3 indicates those 







3.3.5 Notch3 Suppresses Adipogenic Differentiation Through a Non-canonical 
Pathway 
Since PPARγ1 is expressed in multiple cell types, whereas PPARγ2 is exclusively 
expressed in adipocytes, adipogenic differentiation was extended to six days in order to 
obtain a better understanding of the relationship between Notch3 and PPARγ2. Similar to 
hADSCs cultured for three days in adipogenic media, the expression of PPARγ1 and 
PPARγ2 increased while the expression of Hes1 and Hey1 were unaffected by the 
knockdown of Notch3 six days after adipogenic differentiation (Figure 3-7 A and B). To 
further evaluate a role for the canonical Notch3 signaling cascade in the regulation of 
adipogenesis, we performed an siRNA-mediated knockdown of the Notch co-factor RBP-
Jκ. As Figure 3-7 C shows, the loss of RBP-Jκ caused a decrease in the expression of 
Hey1 but had no effect on the expression of Hes1, suggesting that the Hey1 expression is 
more sensitive to the presence of the CSL complex during adipogenesis. Surprisingly, the 
expression of neither PPARγ1 nor PPARγ2 was affected, again raising the question as to 
whether or not the canonical Notch pathway is a significant component in the regulation 
of adipogenesis. Finally, we compared the downstream effect of the simultaneous 
knockdown of both Notch3 and RBP-Jκ in hADSCs followed by six days of adipogenic 
differentiation. The loss of Notch3 did not cause a further reduction in the expression of 
Hes1 and Hey1 but did result in an increase in the expression of PPARγ (Figure 3-7 D 
and E). Since PPARγ expression increased after the knockdown of Notch3 both in the 
presence and absence of RBP-Jκ siRNA, we believe that Notch3 regulates adipogenesis 






Figure 3-7: Notch3 suppresses early adipogenesis in a Hes/Hey-independent manner. 
(A) The change in expression of Notch-associated proteins and PPARγ1/2 after the 
knockdown of Notch3 was determined using western blot six days after inducing 
adipogenesis. (B) Changes in transcript levels of Notch pathway components and 
pparγ following the knockdown of Notch3 were determined six days after inducing 
adipogenic differentiation using qRT-PCR.  All data was normalized to gapdh and 
fold change was determined by comparing data from samples transfected with Notch3 
specific siRNA to those transfected with negative control siRNA. N=3, *p< 0.05, 
**p< 0.01. (C) The change in expression of Notch-associated proteins and PPARγ1/2 
was determined by western blot following the knockdown of RBP-J and six days 
after inducing adipogenesis. (D) The change of Notch-associated proteins and 
PPARγ1/2 was determined by western blot following the knockdown of RBP-J and 
double-knockdown of Notch3 and RBP-J and six days after the induction of 
adipogenesis. (E) Changes in the transcript levels of Notch pathway components and 
pparγ following the double-knockdown of Notch3 and RBP-J.  All data were 
normalized to gapdh and fold change was determined by comparing data from 
samples transfected with Notch3 and RBP-J to those transfected with only the RBP-
J specific siRNA.  N=3, *p< 0.05, **p< 0.01. In all figures, siCtrl indicates samples 
transfected with negative control siRNA, siN3 indicates those samples transfected 
with Notch3 specific siRNA, siRBP-J indicates those samples transfected with RBP-






3.3.6 Adipogenic Regulation by Notch1 and Notch3 is Associated with Wnt 
Signaling 
 As Notch3 is expressed during early adipogenesis and the knockdown of 
Notch3 leads to an increase in adipogenesis, it appears that Notch3 may be a critical 
component of adipogenic commitment. Given that the canonical Wnt/β-catenin signaling 
pathway has been demonstrated to also suppress adipogenesis (Tang & Lane, 2012), we 
examined the level of GSK3β protein six days after inducing adipogenesis. The 
knockdown of Notch1 did not appear to affect the level of inactive GSK3β but did 
significantly reduce the level of total GSK3β protein expressed. On the other hand, the 
level of inactive GSK3β remained unaffected following the Notch3 knockdown, while 
the level of total GSK3β protein slightly increased following the knockdown of Notch3 
(Figure 3-8 A). As it has been demonstrated that the Notch3 knockdown increases the 
protein level of Notch1 (Figure 3-3 A and B), both Notch1 and Notch3 were 
simultaneously knocked down. The decrease of GSK3β following the double knockdown 
further suggests that Notch1 may be involved in regulating the expression or the stability 
of GSK3β (Figure 3-8 A). 
To determine if the variation of GSK3β eventually alters the activity of the 
canonical Wnt signaling pathway, we measured the level of active β-catenin, the substrate 
of GSK3β and terminal component of the canonical Wnt signaling pathway. The Notch1 
knockdown decreased the level of total GSK3β (Figure 3-8 A), but it did not affect the 
amount of active β-catenin in either the cytoplasm or nucleus (Figure 3-8 B). 
Conversely, following the knockdown of Notch3, although the level of GSK3β increased 





decreased expression of GSK3β after the knockdown of Notch1 did not restore the level 
of nuclear β-catenin protein to control levels in the Notch3 knockdown sample. Since the 
change in active β-catenin protein may also result from the variation in the transcription 
of ctnnb1 (the gene that encodes β-catenin), we performed qRT-PCR but did not observe 
a change in the transcription of ctnnb1 following the knockdown of Notch3 and six days 
of adipogenic differentiation (Figure 3-8 C). Collectively, this suggests that Notch3 may 
have a role in regulating the stability of β-catenin with less of a role in the regulation of 
GSK3β expression or activity. 
Since the activity of β-catenin is highly involved in the adipogenic commitment 
of cells, we shortened the period of investigation from six to four days after inducing 
adipogenesis. The transcription level of β-catenin was not changed following the 
knockdown of Notch3 (Figure 3-8 C), but a decrease in the level of active β-catenin in 
the nucleus was observed (Figure 3-8 D). To better understand how the loss of Notch3 
reduces the level of β-catenin, a Co-IP was performed and demonstrated an interaction 
between Notch3 and β-catenin. This physical interaction suggests a possible explanation 
for the protective effect we observed for Notch3 on β-catenin (Figure 3-8 E). However, 
we did not observe Notch3 protein when we pulled down β-catenin. This may be due to 
higher levels of β-catenin in these cells where only a small percentage of β-catenin 
actually interacts with Notch3, thereby diluting the potential signal. To confirm the effect 
that β-catenin and Notch3 have on adipogenesis, cells were transfected with β-catenin 
and Notch3 specific siRNA, respectively. The decreased expression of Notch3 appeared 
to have a similar effect on adipogenesis, as the β-catenin knockdown specifically resulted 





inhibitory effect of Notch3 on adipogenesis may be accomplished through an interaction 
or relationship with nuclear β-catenin. 
 
Figure 3-8: The loss of Notch1 and Notch3 differentially impacts Wnt signaling 
during adipogenesis. (A) Changes in total and inactive GSK3β protein were 
determined by western blot following the knockdown of Notch1, Notch3, or Notch1 
& 3 double knockdown six days after adipogenic induction. (B) Changes in active β-
catenin in the cytoplasm and nucleus were determined by western blot following the 
knockdown of Notch1, Notch3, or Notch1 & 3 six days after inducing adipogenesis.  
(C) The relative levels of CTNNB1 (the gene codes β-catenin) transcript were 
determined by qRT-PCR following the knockdown of Notch3 knockdown in hADSCs 
four and six days after inducing adipogenic differentiation. N=3, p> 0.05. (D) 
Changes in active β-catenin and PPARγ1/2 in the cytoplasm and nucleus were 
assessed by western blot following the knockdown of β-catenin or Notch3 four days 
after inducing adipogenesis.  (E) Notch3 and β-catenin were isolated using co-
immunoprecipitation in the presence and absence of Notch3 siRNA three days after 
inducing adipogenic differentiation. As described in the Methods section, Mock 
indicates samples pulled down with negative control Rabbit IgG. In all figures, siCtrl 
indicates samples transfected with negative control siRNA; siN1, siN3, and si-cat 
indicate those samples transfected with Notch1, Notch3, and -catenin specific 
siRNA, respectively; and siN1+3 indicates those samples transfected simultaneously 







Here we provide evidence for the distinct roles of Notch1 and Notch3 during 
hADSC adipogenesis. Based on our data, we propose a mechanism for further 
investigation where the Notch pathway regulates adipogenesis through a noncanonical 
method and interaction with β-catenin (Figure 3-9). Specifically, we speculate that in 
self-renewing hADSCs, the expression of both Notch1 and Notch3 is low in order to 
maintain basic regulatory activity of these two receptors inside and outside the nucleus. 
Following the initiation of adipogenesis, we observed that Notch3 was upregulated. Since 
we found a direct interaction and a positive correlation between NICD3 and active β-
catenin, we suspect that the increase in the level of NICD3 is associated with the 
activation of the canonical Wnt signaling pathway that functions to suppress adipogenesis 
(Tang & Lane, 2012). On the other hand, the expression of Notch1 did not increase and 
its nuclear activity was low in un-differentiated hADSCs, suggesting that the function of 
the canonical Notch1 cascade may be suppressed during early adipogenesis. As hADSCs 
were directed towards an adipogenic lineage, Notch3 expression decreased, indicating 
that Notch3 likely does not have a role in regulating lipid metabolism during late 
adipogenesis. Notch1 was highly expressed in differentiated hADSCs, and the amount of 
Notch1 increased as the number of cells undergoing adipogenic differentiation also 
increased. However, the increased expression of Notch1 expression did not compensate 
for the low ratio of NICD1 translocating to the nucleus throughout adipogenesis, 
suggesting that cytoplasmic NICD1 may be a critical candidate in the regulation of lipid 





maintenance of stemness while Notch1 may be a factor that regulates the metabolism 
associated with differentiated adipocytes.  
 
Figure 3-9: Model of Notch1 and Notch3 function during adipogenesis.  In self-
renewing hADSCs Notch1 and Notch3 are expressed and appear to regulate cell fate 
in both the cytoplasm and nucleus (left). When cells are stimulated to begin 
adipogenesis, Notch1 is no longer localized to the nucleus, while Notch3 is highly 
expressed.   This increased expression of Notch3 may be responsible for a physical 
interaction that protects β-catenin from phosphorylation and degradation (right). 
Image credit to Tom Futrell, School of Design, Louisiana Tech University. 
 
The contradictions observed throughout the study of Notch signaling are often 
explained by the differences in cell lines used for experimentation.  Comparing our own 
results with those  trends observed in other cell lines we find that Notch3 was expressed 
earlier than Notch1 in hADSCs during adipogenesis, similar to the published results 
using 3T3-L1 preadipocytes (P.-Y. Lai et al., 2013). To confirm the role of Notch1 and 
Notch3 in adipogenesis, target-specific siRNA was applied, again with similar effects on 
the transcription of PPARγ as those observed for full-length Notch1/Notch3 transfected 





behave similarly in both hADSCs and 3T3-L1 preadipocytes offering validation to the 
use of hADSCs as a model for the study of adipogenesis.   
Numerous studies indicate that Notch1 can activate the transcription of Notch3 
via the CSL complex (Ohashi et al., 2010). In our study, the lower expression of Notch3 
following the knockdown of RBP-Jκ was indeed observed; however, the downregulation 
of Notch3 following the knockdown of Notch1 was not clearly exhibited. To answer that, 
we performed IF of hADSC six days after inducing adipogenic differentiation and did not 
observe the co-localization of Notch1 and Notch3 suggesting that the regulatory effect of 
Notch1 on Notch3 might be minimal. Moreover, the absence of NICD1 from the nucleus 
during adipogenesis further supports the implication that Notch1 does not directly 
regulate the transcription and expression of Notch3. Instead, we observed an increase in 
the expression of Notch1 after the knockdown of Notch3 six days into adipogenic 
differentiation of hADSCs, aligning with publications reporting that the forced 
overexpression of full-length Notch3 can reduce the transcription of Notch1 in 3T3-L1 
preadipocytes (Nueda et al., 2018). As the early expression of Notch3 appears to suppress 
adipogenesis, and the high expression of Notch1 only occurs after the formation of lipid 
vesicles, the increased expression of Notch1 after the knockdown of Notch3 may be 
caused by the increased number of differentiated hADSCs, not necessarily by a direct 
relationship or interaction between Notch1 and Notch3.  
Based on the sensitivity of the expression and stable inhibitory effect of Notch3 
during adipogenesis, Notch3 appears to be a critical gatekeeper that maintains hADSCs 
in a stem cell state during differentiation. Since the ratio of nuclear to total protein of 





knockdown on PPARγ2 is minimized with the transfection of RBP-Jκ specific siRNA, 
we believe that Notch3 may regulate adipogenesis in both the nucleus and the cytoplasm. 
Therefore, we attempted to investigate the role of Notch3 in regulating the expression of 
Hes1 during adipogenesis, as pparγ has been reported to be a direct target of Hes1 
(Herzig et al., 2003). However, the downregulation of Hes1 was not observed in cells that 
were exposed to adipogenic media for either three or six days following the knockdown 
of Notch3. Moreover, the knockdown of RBP-Jκ did not diminish the expression of Hes1, 
suggesting the expression of Hes1 may be independent of the Notch pathway. Indeed, the 
Notch-independent activation of Hes1 has been observed in the study of neuroepithelial 
cells (Hatakeyama et al., 2004) and it has been reported that the activated Stat3-Socs3 
complex directly induces the transcription of hes1, suggesting that the role of NICDs in 
controlling Hes1 expression during adipogenesis requires further investigation 
(Kageyama et al., 2008). In addition, Hes1 appears to participate in an autoregulatory 
loop whereby it acts to repress its own transcription, further supporting the idea that the 
regulation of Hes1 exists beyond the canonical Notch signaling pathway  (Hirata et al., 
2002). On the other hand, the transcription of hey1 appeared to be sensitive to the 
diminished expression of RBP-Jκ but not Notch3, suggesting that other receptors might 
be present and signaling through RBP-J to compensate for the decreased expression of 
Notch3. In addition, as the transcription of hey1 can be directly activated by BMP9-
SMAD1/5 or TGF-β-SMAD3/4 cascades in a Notch-independent manner (Wöltje et al., 
2015; Zavadil et al., 2004), it is likely that there is significant interaction and cross-talk 





Finally, since the loss of RBP-Jκ did not increase PPARγ expression, as was 
observed following the knockdown of Notch3, we believe that cytoplasmic NICD3 may 
have a negative role in the expression of PPARγ. Here we show that this is at least partly 
true when considering the interaction of Notch and Wnt signaling. Co-
immunoprecipitation indicated a physical interaction between Notch3 and β-catenin, and 
the knockdown of Notch3 reduced the protein expression but not transcription of β-
catenin both four and six days after initiating adipogenic differentiation of hADSCs, 
suggesting that Notch3 may play a role in protecting β-catenin from degradation. 
However, the decrease in nuclear β-catenin was only observed four days after inducing 
adipogenesis, which may be the result of varied nuclear translocation of β-catenin during 
different stages of adipogenesis. Together our data suggests that Notch3 is a negative 
regulator of adipogenesis through a non-canonical path and indicates a need for further 
investigation to determine the specific mechanisms through which the Notch signaling 














Adipogenesis has been recognized as a critical property of stem cells in the 
regulation of metabolism. To expose the key factors that determine the fate of stem cells, 
the Notch signaling pathway has been the target of a significant number of studies for its 
role in stem cell homeostasis and directed differentiation. Despite decades of 
investigation, the role of Notch in adipogenesis has not yet been fully revealed. In this 
dissertation, we studied and compared the distinct roles of Notch1 and Notch3 in hADSC 
adipogenesis to reveal greater insight into the role of these receptors and method in which 
Notch regulates cell fate. 
We initially began our studies with Notch3 because of the higher level of 
expression of the receptor in self-renewing hADSCs and the limited literature on its 
unique role in adipogenesis. The loss of Notch3 mediated by target specific siRNA 
resulted in increased adipogenesis 14 days after adipogenic induction, which was 
represented by an increased number of lipid vesicles and increased expression of 
adipogenic markers. Therefore, we hypothesized that Notch3 could be the key receptor 





Notch3, we examined the expression profile of Notch3 and observed the expression of 
Notch3 during early adipogenesis. Specifically, we investigated the effect of the Notch3 
knockdown three and six days after inducing adipogenic differentiation of hADSCs to 
determine the role of Notch3 during early adipogenesis. As expected, all induced 
hADSCs exhibited increased adipogenesis after the knockdown of Notch3. However, we 
did not observe a change in the expression of canonical Notch targets leading us to think 
that Notch3 may be acting in the cytoplasm to regulate cell fate rather than directly 
controlling target gene expression. Since -catenin has been characterized as a key 
regulator that prohibits stem cells from preadipocyte commitment, we attempted to 
identify a relationship between Notch3 and -catenin. Indeed, we performed Co-IPs and 
observed a direct protein-protein interaction between Notch3 and -catenin. In addition, 
the knockdown of Notch3 led to a decrease in the level of active -catenin. Therefore, we 
believe that the regulation of -catenin is one path regulated by Notch3 during 
adipogenesis. 
The progress of Notch research in adipogenesis has been complicated by 
continuous contradictory results, which are often explained by the differences in cell 
types and models used by individual investigators. In an attempt to further address 
confusion in the field, we also studied the role of Notch1 in hADSC adipogenesis and 
found that the loss of Notch1 using targeted siRNA resulted in decreased adipogenesis 
six days after adipogenic differentiation. This observation is consistent with other studies, 
although the down-regulation of adipogenic markers was not as significant as what we 
expected. Upon further investigation, we found that the high expression of Notch1 was 





might not be long enough to fully expose the effect of the Notch1 knockdown. More 
importantly, we observed that the nuclear translocation of Notch1 was highly suppressed 
during adipogenesis, suggesting that the transcription efficiency of Notch1 was likely to 
be lower than other Notch receptors. Indeed, when we knocked down both Notch1 and 
Notch3, cells mainly exhibited the effect of the loss of Notch3, indicating that Notch1 
and Notch3 are involved in different periods of adipogenesis, respectively, and Notch3 
plays a leading role in suppressing early adipogenesis. 
The dynamic balance of Notch receptors is another concern that makes Notch a 
complex topic in adipogenesis. Assuming that Notch receptors are capable of functionally 
compensating for each other, any change in expression of activity of a given Notch 
receptor would interfere with the results following the knockdown of the target receptor. 
Indeed, we observed an increase in the expression of Notch1 after the knockdown of 
Notch3. However, IF staining demonstrated a distinct localization profile for Notch1 and 
Notch3, indicating that the increase in the expression of Notch1 was not a result of 
intracellular cascades but an indirect result of increased preadipocytes after the 
knockdown of Notch3.  
 Previous research has invested a lot of time and resources into the study of 
Notch1 but has not yielded consistent outcomes. We observed that Notch3 not only 
functions before Notch1 in adipogenesis, but its inhibitory effect can directly affect the 
subsequent regulation of Notch1 during early adipogenesis, indicating the important 
position of Notch3 in fat differentiation. On the other hand, we also demonstrated the 
dispensability of canonical Notch targets for adipogenic regulation, thus emphasizing the 





found that Notch3 can enhance the inhibitory effect of Wnt on the commitment of 
adipogenesis by protecting -catenin. In summary, we propose that Notch3 may be a 
potential therapeutic target for obesity and diabetes in the future.  
 
4.2 Future Directions 
The on-going research indicates that Notch is a highly dynamic and context-
dependent signaling pathway. Coupled with the complexity of the cell statements during 
fat differentiation, the study of Notch in adipogenesis is even more challenging. Here we 
will briefly explain the origin of the research difficulties and possible solutions. 
Given that the differentiation status of hADSCs are highly heterogeneous during 
early adipogenesis, the cascades that determine cell fate are challenging to isolate. In 
addition, as a boundary determinate, the activity status of Notch may be completely 
opposite in adjacent cells, increasing the difficulty in making universal conclusions 
related to the role of this pathway in certain cellular processes. Therefore, looking for a 
technique to define and separate cells that are at different stage of adipogenesis is critical 
for the study of Notch. For instance, using fluorescence activated cell sorting (FACS) to 
separate cells is a default strategy for accomplishing the study of both mRNA and 
protein. However, since the size of differentiating cells increases from 10 m to over 100 
m, and the laser is potentially randomly reflected by the variation of lipid vesicles in 
each cell, setting up a reliable default gate may be challenge.  Alternatively, if focusing 
on transcription, single-cell RNA sequencing is a powerful technique to isolate and 
investigate the downstream transcriptional effect of Notch receptors in each individual 





with higher resolution is required to expose the detailed distribution of Notch receptors 
and interaction with specific proteins at the level of a single cell. 
For the study of Notch3, we have determined the positive correlation between 
Notch3 and active -catenin during early adipogenesis. Co-IPs demonstrated the protein-
protein interaction of these two molecules. However, these outcomes do not answer the 
question of how Notch3 positively regulates the level of -catenin. For instance, whether 
there are other proteins involved in the binding of Notch3 and -catenin has not been 
confirmed. Also, since -catenin is rapidly ubiquitinated after phosphorylation, if the 
Notch3/-catenin interaction prohibits phosphorylation or simply slows the degradation 
of -catenin requires further investigation.  
The study of Notch1 is still on-going. Our study begins to explain the weak 
regulatory effect of Notch1 with its late expression and poor nuclear translocation during 
adipogenesis. However, the mechanism for Notch1 to promote the expression of 
PPAR still remains unknown. We observed decreased GSK3 after the knockdown of 
Notch1but there was no effect on the level of -catenin.  As there are multiple targets that 
are phosphorylated by GSK3 we believe that investigating the activity of GSK3 
substrates is a way to explain the positive relationship between Notch1 and adipogenesis. 
On the other hand, since Notch1 is highly expressed during late adipogenesis, we believe 
that Notch1 is more involved in the lipid metabolism but not commitment of 
adipogenesis. Indeed, it was reported that Notch1 promoted hepatosteatosis by activating 
mTorc1, a functional substrate of insulin/Akt pathway (Li et al., 2010; Pajvani et al., 






The fight against obesity has lasted decades, but the understanding is still 
insufficient to relieve weight gain at the clinical level. With the increase in research, the 
importance of Notch in metabolic regulation has begun to be revealed. However, since 
the focus on Notch1 leaves many questions, Notch is still regarded as an emerging target 
in adipogenic regulation. Therefore, increasing research on other receptors has become a 
breakthrough in deepening the understanding of Notch in adipogenesis. With continuous 
study, the canonical and non-canonical Notch pathway is expected to become a powerful 
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